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Abstract
Lab-on-a-chip technologies have been employed in many fields of research.
Molecular analysis, microelectronics, chemical and biological assays, cellular
studies and environmental monitoring are a few examples in a large and var-
ied list of microfluidic applications. This thesis covers areas from soft matter
polymer physics to cancer diagnosis and super resolution microscopy.
The first topic is immunoassay or the detection of cancer biomarkers on chip.
The importance of early cancer detection lies in the massive increase in treat-
ment effectiveness the sooner it is administered. In this thesis, the detection
of Prostate Specific Antigen (PSA) is investigated using on-chip immunoassay.
The components of the immunoassay have been characterised from enzyme
reporters to microfluidic droplet generation mechanisms. Single molecules of
enzyme can be detected paving the way for on-chip cancer diagnosis.
Many microfluidic devices are manufactured from polydimethylsiloxane
(PDMS), a soft polymer. The material has many advantages in microfluidics
from optical transparency, low cost, ease of handling, gas permeability and
biocompatibility. Due to its elastic properties, PDMS is prone to deformation
when placed under high pressures. A novel method of pressure measurement is
presented. Along with pressure measurements, the interaction between PDMS
and molecules that diffuse into it are studied. The infiltration of molecules
changes local mechanical properties which effects the internal pressure of a
channel. Raman spectroscopy allows visualisation of the dynamics of material
ingress.
Expansion microscopy is a method of encasing a biological sample in a gel
matrix, removing the sample and leaving behind a fluorescent ghost image. This
gel swells isotropically in water so the fluorescent markers move further apart
and can be resolved through super resolution microscopy. This requires delicate
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1.1 Microfluidics and micro total analysis sys-
tems (µTAS)
Microfluidics is the technology behind the study and manipulation of small
liquid volumes confined to channels or structures that are typically tens to
hundreds of microns in dimension [4,5]. In 1990, Manz et. al. proposed a de-
vice for liquid chromatography whereby the reduction of length scales in the
device can theoretically enhance chromatographic separations, speed up elec-
trophoretic separation and shorten transport times of reagents [6]. The inclusion
of sample preparation, transport, detection and signal evaluation led to Manz
coining the term micro total analysis system (µTAS/microTAS) for such a de-
vice. Integrating many components onto these µTAS devices can replace larger,
more conventional bench based systems for many of these tasks.
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This idea led to the birth of microfluidic technologies and the coining of
the term ’lab-on-a-chip’ [7]. Lab-on-a-chip technologies have been employed in
many fields of research. Molecular analysis, microelectronics [8–11], chemical and
biological assays [12–14], cellular studies [15–18] and environmental monitoring [19]
are a few examples in a large and varied list of microfluidic applications. The
use of microfluidics over conventional larger scale methods leads to a few advan-
tages. The manipulation of small volumes of fluid allow the same operation to
be performed that would require much larger volumes in conventional systems.
The use of these small volumes, on the scale of nanolitres and below can be
advantageous in lowering the cost of reagents as well as reducing risk with the
use of potentially dangerous materials [20]. The reduction in the reaction space
also adds a benefit to such microfluidic systems. Reagents must diffuse shorter
distances when confined in the channels where the dimensions are generally on
the order tens to hundreds of microns, increasing reaction probability [21]. Small
channels are effective when the reaction is to take place on a surface as reac-
tants have less distance to travel before encountering the surface but also can
be replenished quickly while simultaneously flushing the system of previously
unused reactants. Heat transfer in confined geometries is also enhanced as high
surface area to volume ratios enable rapid heat transfer from or to the reaction
or process [21].
The behaviour of fluid flow in microfluidic systems also lends itself to desir-
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able experimental parameters. Flow is laminar, lacking turbulence, where the
fluid flows in well defined parallel layers with little disruption between them [22].
This leads to precise control of flow and predictable behaviour in a given geom-
etry [23]. Very little mixing takes place in the laminar flow regime, which may be
an issue depending on the required reactions (see section 1.1.2.2). This keeps
reagents on a defined path throughout the microfluidic device, which can be
advantageous for detection positions. An example of this is droplet or particle
sorting, where droplets flowing down a channel will encounter a laser spot in a
single file fashion [2] enabling no change in set up once experimentation begins.
Many different components can be integrated into a single device allowing
for complex procedures to be undertaken without the need for larger equip-
ment. Some components are integrated through geometrical means such as
mixers, separators, particle traps [17,24], pumps [25,26], filters [3] and droplet gen-
erators [27,28]. Others can be added to the device through techniques such as
atomic layer deposition, chemical wet etching or even conventional adhesion
techniques (glue or tape) to add features such as electrodes, magnetic compo-
nents or chemical sensors [29–32]. The integration of many components into a
single device increases portability, allowing easy transport to the field or to a
patient’s bedside for quicker testing. Depending on the required procedure, de-
vices can be passive, only requiring the application of a droplet of sample that
is drawn into the device through capillary action to encounter some previously
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placed reagents [33–35]. This miniaturisation, ease of use and rapid results acqui-
sition is a motivation for the continued development of microfluidic systems.
Fabrication of microfluidic devices can be fairly low cost once the initial in-
frastructure is in place, which can lead to rapid replication of devices once the
design has been finalised. The rapid prototyping of devices gives an advantage
whereby the production of multiple prototypes can be done in parallel, for ex-
ample, multiple designs incorporated onto one photomask or multiple designs
drawn by laser writing (see section 2.2 for a thorough explanation). This allows
for many variables such as channel size or droplet nozzle width to be assessed.
Once a final design is complete, mass production can be relatively simple. In
terms of commercialisation, there are often issues with scaling up production of
a particular solution, which can lead to further troubleshooting. With microflu-
idic devices it is fairly simple to multiplex devices through parallel connections
to increase throughput [36].
1.1.1 Microfabrication
The material choice for a microfluidic chip depends on the desired properties
and function of a device. Early development of microfluidic systems used sili-
con as a substrate and used techniques similar to that used in semiconductor
fabrication [37]. These devices require hazardous chemical processes and are gen-
erally difficult to handle due to the brittle nature of silicon. Glass is a popular
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choice due to its optical transparency and resistance to chemicals [29]. The man-
ufacture of glass chips uses photolithography techniques (described in detail in
section 2.2) after which the glass is etched to form the channel depths [38–40].
Thermoplastics such as PMMA (Poly(methyl methacrylate), polycarbonate
(PC), polystyrene, polyethylene terephthalate (PET) and polyvinyl chloride
(PVC) can be used to create devices through moulding, although there are sev-
eral disadvantages. The moulds required are generally metal or silicon meaning
multiple changes in device design during prototyping is difficult (although mass
production is easier). These plastics are incompatible with most organic sol-
vents and not permeable to gas, which makes them unsuitable for applications
such as long term cell culture where gas exchange is required. Bonding of ther-
moplastics can be difficult but is achieved through glue assisted bonding or by
mechanical clamping of channels to a manifold [41].
Soft polymer elastomers consist of crosslinked polymer chains, which exhibit
elastic properties when put under mechanical stress [36]. The most popular of
these is polydimethylsiloxane (PDMS) [29,36,38,42,43]. PDMS is low cost and easy
to fabricate with, making it a staple in many microfluidic labs. The liquid
polymer cures between 40 - 70 ◦C and is cast using impression moulding capa-
ble of copying nanometre resolution templates [29]. After casting (a technique
named soft lithography, described in section 2.4) the device can be reversibly or
irreversibly bonded to a substrate (usually glass) by simple contact or exposure
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to oxygen plasma respectively. Multilayer channels can be created by stacking
PDMS mounds on top of each other with cylindrical connectors to connect dif-
ferent layers [44]. If the membrane between multiple layers is sufficiently thin,
the high elasticity of PDMS can be used to create valve structures that actuate
through the introduction of pressure into a channel. These valves have small
dead volumes and can be very densely packed onto a chip [45–47].
1.1.2 Microfluidic Flow
1.1.2.1 Laminar Flow and Reynolds Number
Fluid flow in microfluidic devices is laminar whereas in bulk systems the flow
is predominantly turbulent [22]. This turbulence enable fluids to mix together
without external influence. The mixing in laminar flow only occurs due to
diffusion between streams of fluid in contact with each other. Laminar flow
occurs when viscous forces dominate the inertial forces in a system [21,48–51]. To
determine whether a flow is laminar or turbulent, the Reynolds number can be




























































































































































































































































































































































hydraulic diameter of the channel (m) and µ = fluid viscosity (kg m−1 s−1).
The hydraulic diameter of a channel depends on the area of the channel and





At Reynolds number less than 2300, flow is predicted to be laminar and
generally microfluidic devices operate at Reynold numbers less than 1 [22,52–54].
Diffusion of molecules is determined with the Einstein-Smoluchowski equa-




where x = diffusion distance (m), D = diffusion coefficient (m2s−1) and t =
time (s). Diffusion arises due to concentration gradients of molecules within a
system. An example of the importance of this relation in regards to microflu-
idics can be seen in the diffusion of haemoglobin in water. Haemoglobin has
a diffusion coefficient D = 7 x 10−7 m2s−1 therefore takes 106 s to travel 1 cm
but only 1 second to diffuse 10 µm [21]. In a microfluidic channel, the high con-
centration of fluid compared to the surrounding material causes diffusion into
that material and, due to the small length scales characteristic in microfluidic
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devices, can be a significant effect [22].
The resistance of a microfluidic channel can be shown in a way analogous
to electronic circuitry [56]. Ohm’s law states that R=V/I for resistance, voltage





where Q = volumetric flow rate (m3s−1), ∆P is the pressure drop of a
channel from beginning to end (Pa) and R = hydraulic resistance of the channel
(Pam−3s). When analysing microfluidic designs, these analogies are useful as
series and parallel rules still apply. Series channel resistances are summed and










The hydraulic resistance of the channel is dependent on the geometry of
the channel and is derived from analytical solutions to the Navier-Stokes equa-
tion [22]. The resistance of a circular channel is given in equation 1.6 where µ
is fluid viscosity (kg m−1 s−1), L is the length of the channel (m), and r is the
radius (m). Generally, when manufacturing microfluidic devices, the result-
ing channels are rectangular. The resistance of a rectangular channel is given
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equation 1.7 [49] where h is the channel height and w the width (This equation









1.1.2.2 Mixing on chip
When performing reactions on chip, it may be necessary to enhance the mixing
within a microfluidic channel. Turbulence only occurs at Re> 2000 and requires
high flow rates to achieve [48]. To improve the mixing performance of channels,
serpentine sections can be added. Song et al. [57] observed the mixing in straight
and serpentine channels with a 3 phase water droplet in a polyfluorodecaline
(PFD) stream. One water stream contained a solution of ferrothiocyanate as
a red dye. The plugs were formed at a t-junction where the shear force of the
PFD broke the water solution off into 100 µm long plugs. When the channel
is straight, the plugs encounter steady recirculating flow due to interaction
with the channel wall but does not mix between phases. When a serpentine
channel is used, the offset in symmetrical forces from the wall due to curvature
causes the plug to be thoroughly mixed. The serpentine was injected with a
10
calcium sensitive fluorescent dye and a calcium solution and imaged showing
fluorescence evolution over time [57]. This geometry was used in immunoassay
experiments in this thesis to provide reactant mixing.
Figure 1.1: A serpentine from the immunoassay device used in this thesis. This
mixer is placed directly after a droplet generation nozzle to evenly distribute
reactants.
Figure 1.2: A serpentine causes offset in circulating flows within droplets caus-
ing mixing. Adapted from Song et al. [57]
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1.1.2.3 Microfluidic Valves
Microfluidic valves were described in section 1.1.1 and are useful for controlling
flow patterns within a microfluidic device. The valves are fabricated from mul-
tiple layers of PDMS containing channels. Shown in figure 1.4, the horizontal
flow channel lays above a perpendicular vertical channel. Figure 1.5 shows the
working principle of a microfluidic valve from a side view. Spin coating the
PDMS onto the bottom layer allows fine control of the membrane thickness
between the channels to tune the valve properties. Unger and Quake developed
the method of preparing these valves and demonstrated their blocking abili-
ties [45]. In the microfluidics community these features have become known as
“Quake Valves”. The valves are actuated by a pressurised air supply on the
order 100 kPa and close in a time on the order of 1 ms as the thin membrane
deforms up into the channel above. Rectangular valves may not create a perfect
seal with the channel above but are sufficient for the diversion of particles or
droplets within microfluidic systems. Sequential valves along a channel were
shown to act as a peristaltic pump on chip by selective activation of a sequence
of valves. The ability to form high density areas of valves makes then favourable
for large scale and complex systems such as that displayed by Thorsen et al. [47].
The large system was analogous to a binary computer system where individual
droplets of water were accessible for transfer between trap areas of merging
with other droplets.
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Figure 1.3: Combining large banks of microfluidic valves allows for the move-
ment of discrete liquid plugs around the chip. Shown is a chip designed to mimic
computer logic using different colours to represent logical states. Taken from [47].
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Figure 1.4: The layering of soft polymer PDMS microfluidic channels with 15
µm membranes between allows for the formation of flow control valves. Scale bar
= 200. Taken from µm [45]
(a) (b)
Figure 1.5: a) A microfluidic valve system in a 3-layer PDMS device. b) when
air is injected, the membrane deforms and blocks the channel above.
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Although PDMS is a common choice for construction of microfluidic valve
structures, alternative materials such as 3D printed resins [58] and acrylic glass [59]
have been shown to operate on the same principle. In a study by Guevara-
Pantoja et al. [59] poly(ethylene diacrylate) was 3D printed at a thickness be-
tween 10 - 25 µm and the application of 20 - 40 kPa of pressure was sufficient to
close the valve. These valves were also shown to be integrated into large scale
devices by designing an array of 64 valves similar to the Thorsen et al. sys-
tem [47] and building peristaltic pumps from multiple valves. Milling of acrylic
glass to 100 µm membranes were suitable to be actuated by 17 kPa of pressure
to seal channels.
1.2 Droplet Microfluidics
The final microfluidic component to be described is the droplet generating noz-
zle. Droplet microfluidics differ from continuous flow systems in that they are
used to generate uniform, discrete volumes of fluid within a second immiscible
fluid [60]. Generation of monodisperse droplets in the nanometre to micrometre
diameter range can be achieved at rates up to MHz [3,61,62].
The generation of droplets is governed by the capillary number, Ca. This
value describes the relative importance of viscous forces (shear stress) against
the interfacial tension between the two immiscible fluids at the interface. Ca
15
predicts the droplet formation regime under which the discontinuous phase is








Equation 1.8 describes the capillary number where µ is the fluid viscosity
(kg m−1 s−1), v is the fluid velocity (ms−1, γ is the interfacial tension (N
m−1), Q is the volumetric flow rate (m3s−1) and A is the channel area (m2).
Ca is calculated for both of the phases however the continuous phase plays a
greater role in defining the regime [64]. The Weber number (We) defines the
relative importance of inertial forces against interfacial tension acting across
the interface of two immiscible fluids and is given in equation 1.9 where d0 is
the diameter of the discontinuous phase (m). The Weber number is typically
calculated in reference to the discontinuous phase. The Weber number aids
predictions for geometries where the inertial forces are no longer negligible (We







There are three main geometries of droplet generation in microfluidics, coax-
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ial, flow focusing and cross flow (T-junction) each of which are shown in figure
1.6. Coaxial flow is set-up so the inlet of the discontinuous phase is inside a
channel of the continuous phase, this can be achieved by inserting a capillary
into a wider channel. Flow focusing joins the two phases at a geometric restric-
tion or nozzle in a common flow direction and cross flow employs a T-junction
where the discontinuous phase is introduced perpendicular to the continuous
phase.
In a T-junction, the discontinuous phase enters the channel of the continuous
phase and an interface is formed. The shear forces generated by the continuous
phase and pressure gradient cause the discontinuous phase to elongate into the
main channel until the elongation thins enough for breakup to occur. Droplet
size is controlled by relative flow rates, channel dimensions and relative fluid
viscosity [60]. In flow focussing, the phases are forced through a local constriction
in geometry [3,60,66,67]. The discontinuous phase is symmetrically sheared by the
continuous phase enabling controlled and stable droplet generation [60]. A flow
focussing nozzle creates a single point of high shear at the narrowest region of
the nozzle in which all droplets are produced. This forms uniform monodisperse
droplets.
Figure 1.6 shows the different regimes depending on the Ca. Low Ca pre-
dicts the dripping regime where the discontinuous phase is held at the nozzle
and packets of the discontinuous phase rapidly shear off the tip. A high Ca
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predicts a jetting regime, where the continuous phase travels through the noz-
zle and destabilises into droplets a distance downstream of the nozzle. This
Rayleigh-Plateau instability can be explained in several ways. One is that the
large surface area of the jet is thermodynamically unfavourable so to reduce
its energy, the surface tension drives the formation of droplets with the same
total volume but lower surface area [68]. A second description uses the Laplace
pressure, or pressure between two phases due to the presence of a curved inter-
face. As the jet travels down the channel, the curvature and Laplace pressure
increases. This pressure squeezes the jet to form droplets [68]. At higher Ca
the interfacial forces are no longer overcome and the phases exist in a stable,
laminar coflow regime [69]. When using a flow focusing geometry, capillary num-
bers of Ca = < 10−1, > 10−1 and  10−1 predict dripping, jetting and coflow
respectively [51].
The co-flow mechanism can be used to generate double emulsions using a
microfluidic device [68,70]. Glass capillaries can be nested within each other to
produce oil-water-oil (O/W/O) or water-oil-water (W/O/W) emulsions. The
layout of such a device is shown in figure 1.7. These double emulsions have
been shown to be useful in the formation of spherical hydrogels [71] and protein
crystallization [72]
The stability of droplets in the continuous phase can be improved through
the use of surfactants [73]. Droplets without interfacial stabilisation will coalesce
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Figure 1.6: Microcapillary generation of double emulsions uses two co-flow jets.
The outer fluid is immiscible with the middle and the middle with the inner.
Figure 1.7: Capillary number effect on droplet formation regimes of the three
most common droplet generation geometries, (a) coaxial, (b) flow focussing and
(c) T-junction. Taken from [51]
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Figure 1.8: From Zhu et al. [72], generation of W/O/W emulsions. a,c) Optical
microscopy images of single and double emulsions produced using FC-40 fluori-
nated oil and DI water. b,d) Performance of the nested capillary device used
to generate the single and double emulsions. e)Double emulsions are tunable to
generate single or multi core droplets. f) The ratio of inner aqueous flow rate to
middle oil phase flow rate causes volume variation of the innermost phase.
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on contact and form larger droplets. This is a disadvantage when trying to
generate discrete monodisperse reaction vessels when high droplet densities are
required [3]. Surfactants are amphiphilic molecules with affinities for different
immiscible phases. This drives the molecules to the interface and the surface
tension is decreased [73]. The decrease is given by the Gibbs adsorption isotherm
for dilute solutions:





where Γ is the surface concentration, c is the surfactant bulk concentration,
γ is the surface tension, R is the gas constant and T temperature. Common
surfactants include Triton- X-100 or SDS in silicon oil [74–76], Span 20/80 in
hydrocarbon oils [77–81] and fluorosurfactants (block chain copolymers such as
PEG – PFPE) in fluorinated oils [3,73,82–85]
Figure 1.9: Block co-polymer surfactant used in the droplet formation experi-
ments of this thesis, Krytox 157 FSL Jeffamine ED-600 disalt
Droplet microfluidics has a wide range of applications as droplets are used as
high throughput reaction vessels for biological [86–88] and chemical [89–94] analysis.
Biological applications include single cell analysis [95–101] where droplets contain-
ing cells can have genome analysis, cell matrix interactions and biomarker pro-
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duction observed [16]. The detection of biomarkers and more specifically cancer
biomarkers are the motivation behind chapter 3 of this thesis.
Droplets within microfluidic devices can be manipulated depending on their
contents [2,102–104]. Droplets can be sorted by size or through some external field
such as electrophoresis, examples of which are shown in figure 1.10. These
sorting methods can allow for concentration of targets or removal of unwanted
droplets within a system. Another example of droplet sorting involves the
measurement of a fluorescent product within droplets as the pass a laser and
if a detectable signal is read, an electrode is activated diverting that particular
droplet elsewhere on chip [2]. An example of sorted droplets is shown in figure
1.11.
Figure 1.10: Droplet sorting in a microfluidic device. a) Passive sorting can be
achieved where droplets arrange by size in the channel due to the flow profile. b)
Active sorting through electrophoresis where the electric field is inactive ii) and
active iii). Taken from [1].
The trapping of droplets is a useful tool for time-dependant observation of
a process as well as keeping track of particular droplets. Shown in figure 1.12,
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Figure 1.11: Active droplet sorting in a microfluidic device. a) A large increase
in fluorescent signal causes the activation of an electrode to divert a droplet.
Droplets before b) and after c,d) sorting show that on 0.2% of rejected droplets
have a positive fluorescence signal. Taken from [2].
single droplets can be trapped within pockets built into a channel. Large arrays
of these traps allow single occupancy traps with the possibility of reversing the
flow to release them [1].
Larger scale traps can trap many droplets in a monolayer and allow obser-
vation over a number of minutes to hours [3]. In figure 1.13 from Shim et al. 104
droplets of diameter 4 µm are trapped in a 300 µm trap that uses a monolithic
microfluidic valve to keep the droplets contained.
23
Figure 1.12: Droplet trapping in a microfluidic device. a) The flow profile
around a trap encouraged droplets to enter. Once occupies the remaining droplets
flow around. b) Microscope image of a trap array showing single droplet occu-
pancy. c) Droplets can be released by inverting flow within the array. Taken
from [1]
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Figure 1.13: 10 4 droplets are trapped in a monolayer in a 5 µm thick chan-
nel. These droplets were trapped for 10 minutes to observe the formation of a
fluorescent product. Taken from [3]
1.3 Immunoassay on Chip
Cancer is a group of diseases that are characterised by abnormal growths of
cells and tissue which can invade healthy organs and cause death [105]. The need
to detect and diagnose such conditions during early stages is important in or-
der to apply effective curative interventions before the disease progresses too
far [106]. Imaging techniques are useful for diagnosing these abnormal growths,
or tumours, but rely on the size being sufficient to detect, and scans can also be
interpreted as a false positive [107]. Blood tests have become more popular due
to the increasing sensitivity of screening for cancer biomarkers [31]. A cancer
biomarker is defined as a substance or activity that can be objectively mea-
sured and evaluated as indicator for a normal biological process, pathogenic
process or pharmacological response to a therapeutic environment [108]. Can-
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cer biomarkers are present in tumour environments and can be a wide range
of biological molecules including cell receptors, enzymes, proteins, DNA/RNA,
transcription factors and other small metabolites [109]. Detection methods of
cancer biomarkers traditionally include electrophoresis, surface plasmon res-
onance (SPR) [110–112], surface enhanced Raman spectroscopy (SERS) [113–117],
polymerase chain reaction (PCR) [118] and enzyme-linked immunoassay assay
(ELISA) [34,35,119,120].
Microfluidic systems for bioanalytical applications have been developed
rapidly over the last decade and bridge the gap between simple use lateral
flow type systems and laboratory based analytical techniques [87]. Lateral flow
systems are generally paper based and only require the application of a sam-
ple to a sample pad. Upon application, the sample migrates along the paper
through capillary flow towards a test area loaded with an indicator. A classic
example of a lateral flow device is a pregnancy test, where urine is introduced
to the sample pad which migrates towards an area containing antibodies for the
hormone human chorionic gonadotropin (hCG) that have been conjugated with
coloured beads. The conjugated antibodies bind to the hCG, if present, in the
sample and migrate to a “Test” line where they will bind to a secondary anti-
body for hCG. The accumulation of complexes of hCG and colour-conjugated
antibodies give rise to the band seen on a positive test. Lack of hCG in the
urine sample causes no accumulation of antibody at the test line and therefore
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a negative test [121]. A schematic of this process is shown in figure 1.14. The
advantages of lateral flow devices include the rapid readout time, ease of use,
single step operation, portability and qualitative results. The tests can rapidly
indicate a positive test for a sample analyte but lateral flow devices generally
struggle to yield qualitative results, especially at low concentrations [121].
Figure 1.14: A) Schematic of a lateral flow assay. Top: a sample is added to
the sample pad and migrated towards the conjugated antibodies through capil-
lary action. Middle: Target analyte binds with the conjugated antibodies and
(bottom) migrates to the test line where bound targets are captured. B)This
lateral flow assay is applicable to pregnancy tests where possible outcomes are
shown. Taken from [121].
Building on these simple lateral flow assays, microfluidic devices have devel-
oped to provide sensitive quantitative measurement of analyte concentrations.
The majority of these developments use a heterogeneous sandwich immunoassay
for biomarker detection. ELISA is considered a gold standard for the detection
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of proteins in physiological samples [122] and is used to detect a wide variety
of cancer biomarkers [123,124]. In traditional bulk ELISA methods, a signal is
generated (usually colourmetric or fluorescent) to indicate a concentration of
target analyte bound to a signalling mechanism [119]. Colourmetric assays use
the conversion of a substrate from colourless to a coloured molecule through
enzyme activity. The intensity of the produced coloured molecule is then mea-
sured through absorbance spectroscopy techniques [119]. Figure 1.15 shows the
schematic of an ELISA system. A capture antibody with affinity for the target
biomarker is bound to a surface, usually a 96 well plate. The target sample
is then introduced where the biomarker binds to the antibody. The wells are
washed and a secondary detection antibody is introduced which also binds to
the target analyte. This second antibody is tagged with biotin so that when
a solution of streptavidin conjugates enzyme is introduced, they bind, forming
an immunocomplex. Introduction of a substrate for the enzyme to react with
will result in the production of an observable product that can be measured
by absorption and fluorescence. The most common detection enzymes used are
horseradish peroxidase (HRP), alkaline phosphotase (AP) and β-galactosidase
(β-Gal) [119] as a large range of substrates are available depending on the de-
tection method. Detectable concentration limits using these enzyme systems is
between 25 - 200 ng ml−1 [119]. There is still an unmet clinical need for the detec-
tion of biomarkers of neurodegenerative diseases and cancers that are present
in biological fluids at concentrations of 10−12-10−16M [106,125]. This section will
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discuss examples microfluidic based immunoassays and discuss the different
techniques used with their advantages and disadvantages. A summary of the
performance and format of microfluidic immunoassays is provided in table 1.2.
Figure 1.15: Schematic of sandwich ELISA. A capture antibody bound to a
surface captures the target biomarker after the introduction of a sample (blood,
saliva etc.). A detection antibody binds to the target and provides a binding site
for the reporting mechanism, here shown as a streptavidin conjugated enzyme.
The enzyme turns over a substrate to develop a detectable signal.
To develop a feasible microfluidic platform for biomarker detection, it is
important to determine the limit of detection (LOD). The LOD describes the
minimum concentration of target analyte that can be distinguished from the
background signal of the detection method. The minimum signal that is defined
as detectable has a signal to noise ratio of 3 which is equivalent to a blank
signal + 3σ where σ is the standard deviation of the blank signal. This LOD is
crucial when developing assays for different disease biomarkers where clinically
relevant concentrations can differ by several orders of magnitude [123,126]. The
blank measurement of an assay can vary depending on the sample type and
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Figure 1.16: Schematic of sandwich ELISA where an immunocomplex is formed
on a bead as opposed to on a surface in traditional ELISA.
composition due to the presence of other biological molecules other than that
of interest in the sample matrix. Interactions between the biomolecules present
and the assay sensing components within a device can cause unwanted positive
results [127].
Sandwich immunoassays begin with the immobilisation of an antibody to
a solid phase followed by the blocking of remaining binding sites. In a mi-
crofluidic device, it is important to consider the surface characteristics of the
devices being designed. The simplest method of binding antibodies is through
a passive adsorption [87] where non-polar regions of the antibody bind to hy-
drophobic surfaces such as plastic. This method is used in the traditional well
plate based assays [128]. A simple microfluidic approach to this method shown
by Fan et al. immobilized antibodies in strips on a PDMS surface and intro-
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duced samples perpendicular to these strips to form an array of squares where
chemiluminescence could be observed [129]. A schematic is shown in figure 1.17.
This system detected α fetoprotein, a biomarker for hepatocellular carcinoma,
at concentrations of between 12.5 - 200 ng mL−1. This method is simple to per-
form but is limited in terms of sample number and concentration limit, in this
study 36 samples were observed. A similar approach by Wang et al. (shown
in figure 1.18) measured testosterone concentrations between 0.03 and 30 ng
mL−1 [130]. In this study, the antigen was bound to the surface before the addi-
tion of a primary and secondary labelled antibody. This is known as indirect
ELISA [119].
Figure 1.18: a) The formation of an indirect ELISA where antibodies bind
to an immobilised antigen. b) Similar to Fan et al. [129], stripes of immobilized
molecules are formed before the introduction of detection molecules perpendicu-
lar creates an array of signals. Taken from [130].
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Figure 1.17: Schematic of an α fetoprotein immunoassay. a) Antibodies are
immobilized on a PDMS surface using a row of channels as a guide forming anti-
body strips b). The PDMS guide is removed, washed and placed perpendicular
to the strips c) where antigen and secondary antibodies are injected. The enzyme
substrate for HRP was added and chemiluminescent signal measured d). Taken
from [129]
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Chip Material Target Analyte Sample Type Time Detection Range Ref
PDMS Testosterone Serum & Urine 100 min 0.03-30 ng mL−1 [130]
PDMS α Fetoprotein Commercial N/A 12.5-200 ng ml−1 [129]
PDMS TNF-α Commercial N/A N/A [131]
PDMS Multiple protein Cell lysates N/A Dynamic [132]
PDMS Protein nucleic acids Cell lysates 20 min Dynamic [133]
PDMS HIV Oligonucleotide Serum 75 min Dynamic [134]
Glass IgG Commercial N/A 0-68 ng ml−1 [135]
Paper IgG Serum 30 min Dynamic [136]
PMMA & Paper Hepatitis B antigen Serum < 60 min 3.4 x 102 - 3.4 x 108 pg ml−1 [137]
PDMS β-galactosidase Commercial 8 mins > 10 nM [138]
Optical Fibres β-galactosidase Commercial Not stated 72 fM [139]
Optical Fibres TNF-α & PSA Plasma 6 hours 2.5 fg mL−1 TNF-α & 0.014 pg ml−1 PSA [126]
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PDMS PSA Commercial 30 min 2 aM - 100 fM [140]
PDMS PSA Commercial 10 min 1.2 - 140 pg mL−1 [3]
PDMS anti Ebola IgG Commercial 15 mins 10 nM - 100 fM [88]
Table 1.2: A comparison of material, sample type and performance of microfluidic immunoassay systems.
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The initial step for designing a microfluidic droplet based ELISA is to
develop the detection method. Microfluidics offers an advantageous detec-
tion platform to detect biomarkers at lower concentrations than traditional
ELISA [31,141]. At low biomarker concentrations, the observed signal is so di-
minished that it cannot be distinguished from background noise. This can be
visualised when considering tens to hundreds of target biomarkers within a sam-
ple. In a 96 well plate, the volume is typically around 300 µl and such small
numbers of enzyme product molecules within this volume are not sufficient for
detection. The use of nano-femtolitre droplets provide smaller volumes where
these small number of molecules are contained generating a higher effective
concentration. Detection can be achieved either in flow [142–144] or in discrete
reaction units. Rondalez et al. developed a microfluidic device with 5 µm wide
hemispherical chambers that were simply placed on a slide containing enzyme
solution [138]. A schematic can be found in figure 1.19 This created discrete
volumes of 1.4 fl on the slide surface. Mixtures of horseradish peroxidase en-
zyme (HRP) and β-galactosidase were mixed with a fluorescent substrate and
trapped in the wells. Continuous monitoring of a selection of droplets over time
led to three bands of intensity increase indicating the presence of zero, one or
two enzymes within. This is an important feature as the detection of single
enzymes leads to the possibility of single biomarker detection through ELISA.




Figure 1.19: a) A PDMS mould was created with 5 x 5 µm chambers which were
placed on a glass slide with a droplet of sample. When pushed from above, the
PDMS formed a 1.4 fl chamber in which the reaction of β-galactosidase enzyme
and fluorescent substrate was observed (b). Taken from [138].
disadvantage is in the number of observable chambers. Rissin et al. devel-
oped an array of wells by sealing an optical fibre bundle to a slide containing
enzyme solution, similar to Rondalez et al. Again, single enzyme behaviour
was observed in these chambers (2.5 x 105 individual femtolitre wells of volume
46 fL), at concentrations of 72 fM [139]. This technique was refined by etching
the optical fibre to customise the chamber dimensions [139,145,146]. This ability
to change the reaction volume is advantageous as it can increase the limit of
detection due to larger volumes enabling a higher probability of capturing a
single molecule in a more dilute solution. The fibre array has its disadvantages
in the number of observed reactions. In order to further decrease the LOD,
there is a requirement to observe more of the sample solution. Increasing the
volume of the reaction vessel comes at a trade off as the amount of time required
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for a detectable signal to be generated by a single enzyme molecule increases.
Another way to combat this is to add fibres to the array. The volume of the
reaction is set at the beginning of an experiment and may, depending on the
concentrations being investigated, require multiple attempts to fine tune the
required volume.
Trapping single molecules in wells or droplets is governed by Poissonian
statistics [3,126]. The ratio of trapping wells to target molecules dictates the
probability of different numbers of molecules being captured in one well. The
Poission equation describes these probabilities and is shown in equation 1.11
where P (k) is the probability of k events of a capture event with average success
λ. When detecting single enzymes (digital counting) the concentrations are
made low so that the probability of one enzyme being present is low and the
probability of two is so low that it is statistically unlikely. Table 1.3 shows the
probabilities of zero, one and two molecules being captured when the average
occupancy is 0.1, 0.01 and 0.001. This shows that if an experiment is observing
1000 individual reaction vessels at 10 % occupancy, there will be on average 4.5
where 2 molecules are trapped. This must be taken into consideration when
observing single molecule reactions.





Mean P(0) P(1) P(2)
0.1 (9.4 pM) 90% 9% 0.45%
0.01 (0.94 pM) 99% 0.99% 0.005%
0.001 (94 fM) 99% 0.099% 1%
Table 1.3: Poission probabilities for 3 droplet occupancies.
The use of droplets as enzyme detection vessels has advantages over previ-
ously mentioned techniques. The ability to control droplet size through flow
rates requires no changes to device design as would be the case in fibre optic or
cast well designs [138,139,147]. Courtois et al. [148] investigated the use of droplets
as enzyme reactors and the leaking of small molecules from droplets into the
continuous phase. Stabilisation of droplets with Abil EM 90, a silicon based
polymeric surfactant, and a 5 % Bovine Serum Albumin (BSA) solution re-
duced leakage of fluorescent products from droplets into neighbouring empty
droplets. Showing this stability paved the way to translating ELISA from a
bulk technique to a valid detection system. A schematic of the device used
is shown in figure 1.20. The device generates droplets and lead to a storage
area where the droplets are incubated for several hours. The storage system
is simple, once stable droplet generation is achieved, the tubing connecting the
syringe drivers to the chip were cut. However, this interruption of flow causes
instability in the channel pressure and the final produced droplets are typically
larger than they were in the previous stable formation. This is evident in figure
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1.21 where there is a polydispersity. Although the use of a stabiliser and BSA
solution reduced the leakage of fluorescenct molecules into neigbouring droplets,
it did not eliminate it. The confinement of fluorescent molecules in the droplet
they were produced in is key in single molecule detection as transfer into other
droplets produces false positive readings.
Figure 1.20: This microfluidic device generates droplets for observation in a
storage area. Channel height = 25 µm. Enzyme/substrate solution was injected
into an aqueous inlet (M) where it joins an oil inlet (O) at a flow focussing junc-
tion (N, 10 µm) to generate droplets. A serpentine mixer leads into a reservoir
(P) where a = 7.72 mm, b = 7.3 mm, c = 7.2 mm, d = 5.78 mm. This contains
four pillars (e = 3 mm, f = 300 µm) and a 30 µm outlet channel. Taken from [148].
Figure 1.21: Droplets generated by the chip in figure 1.20 after 6 hours of in-
cubation show the production of a fluorescent signal. Fluorescent molecules have
leaked from the brighter droplets into the darker population. Taken from [148].
Rissin et al. [126] displayed the ability to detect prostate cancer biomarker
(PSA) at concentrations of 0.4 fM using a similar method to their previous stud-
ies with bunched fibre optics [139]. The immunocomplex traditionally formed on
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a surface in ELISA was translated to a bead based ELISA. Shown in figure
1.22, primary antibodies were conjugated onto 2.7 µm diameter beads to act
as the surface. The beads were mixed with a solution of PSA at concentrations
so that, under Poissonian statistics, only one target biomarker would bind to
the bead. The beads were washed and the detection antibody/enzyme com-
plex was bound. This solution was placed under the fibre bundle after mixing
with the enzyme substrate and fluorescently imaged after an incubation time
of 2.5 minutes. The ratio of the number of fluorescent chambers to the total
number of beads (of known concentration) can be used to infer bulk biomarker
concentration. This work showed that the ELISA process is transferable to a
confined droplet system and that concentrations of biomarker below that which
a standard ELISA test can detect are possible to measure. The key advantage
of sub-ELISA concentration detection of PSA is monitoring of patients who
have undergone a prostatectomy as a treatment for prostate cancer. This op-
eration removes the prostate and should halt the production of PSA within
the body. An increase of PSA levels post operation can indicate a biochemical
recurrence of cancer [122,149–151] and affects approximately 35% of prostatectomy
patients [152]. The lower the limit of detection, the earlier this increase can be
detected.
Bead based ELISA was demonstrated by Kim et al. [140] where bead solutions
were injected into a device containing etched wells formed from a hydrophobic
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Figure 1.22: Digital ELISA of PSA with femtolitre fibre optic wells. a,b)
Single protein molecules are captures on antibody coated beads with standard
ELISA reagents. These are loaded into wells and sealed with a gasket before
incubation and imageing. c) Scanning electron microgrpah of beads within wells.
d) Fluorescence of beads after detectable signal was generated. Taken from [126].
fluoropolymer in an open storage area where the beads settled before slowly
replacing the fluid above the wells with a flow of oil. This produced discrete
droplets that were measured in a similar way to that which has been previously
described, achieving a 2 aM detection limit of prostate specific antigen with
3 droplets fluorescing in an array of 5593 droplets [140]. A schematic of this
method is shown in figure 1.23 Magnetic beads have also been used in a similar
fashion to Kim et al. where the beads are actively transported to the wells
through magnetism rather than gravitational effects [153]. This device is capable
of observing 1 million beads with a bead capture efficiency of around 23%
of injected beads. This small efficiency could lead to loss of many enzyme
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conjugated beads at lower concentrations making lowering LOD difficult. The
throughput of the system is also slow due to the necessity to ensure all beads
have been removed from the patterned surface before a second sample can be
measured. This may limit screening of multiple biomarkers in a short space of
time with this system.
Figure 1.23: a) A solution of ELISA beads and enzyme substrate are injected
into a channel containing a micro-patterned surface with 5 µm circular wells.
After settling, the excess aqueous solution is displaced with an oil phase to form
droplets in each well. After incubation, these are observed using fluorescence. b)
3 µm beads are trapped in water in oil droplets immobilized on the hydrophilic
surface. Taken from [140].
Shim et al. showed the detection of PSA using femtolitre water in oil
droplets of diameter 4 µm generated at a frequency of up to 1 MHz [3]. These
droplets mixed the bead based immunocomplex and fluorescent enzyme sub-
strate at the droplet generating flow focusing nozzle as shown in figure 1.24.
Using integrated monolithic microfluidic valves, the droplets were trapped in
40 arrays of up to 5600 droplets each. This system was able to detect PSA at a
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level of 46 fM. The advantages of such a droplet based system include the high
throughput measurement as well as the ability to adapt the rector volume to
tune experimental conditions. Due to the high rate of droplets production, after
a sample has been measured the valve controlling the droplet storage area is
released and new droplets can flow in, minimising time between measurements.
The disadvantage of the device design is that many droplets are wasted while
the current sample is incubating. The bead capture efficiency of this system
was reported to be on the order of 10 % limiting the number of measurable
beads and therefore the limit of detection.
The level of PSA in a healthy patient is high enough to saturate typical
digital counting microfluidic ELISA systems. Piraino et al. combined digital
counting immunoassay with traditional ELISA to create a device capable of
spanning 5 orders of magnitude in detectable concentrations [88]. The tradi-
tional ELISA element comprises of 200 µm wide x 15 µm high chambers where
neutravidin had been attached to the bottom surface after which primary an-
tibodies were conjugated. The digital chambers were of the same dimension
but incorporates a pressure actuated button containing 5 µm x 5 µm cham-
bers which pressed down into the chamber forming discrete wells. These wells
are named MITOMI (mechanically induced trapping of molecular interactions)
The schematic in figure 1.25 shows the two separate systems working together
in one device. 16 chambers are available to perform different immunoassays
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Figure 1.24: a) Femtodroplets are generated with a 10 x 5 µm flow focussing
nozzle combining an ELISA-bead prepared off chip with FDG substrate. b) The
device contains two layers, one for flow and one for control. After generation,
the droplets can be redirected using valves into a storage area with 300 x 300
µm traps (c,d) capable of storing 5000 droplets. Taken from [3].
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allowing for multiplexed detection. This device was integrated with a USB
camera and shown to have potential applications in field based scenarios or
low resource settings. The operation of the device can be complicated as the
network of pressure control channels is complex. This device was used to detect
anti-Ebola IgG from 10 nM down to 100 fM. The ability to detect this large
range with individual chambers allows for the multiplexing of multiple target
biomarkers where the clinically relevant concentrations differ by many orders
of magnitude.
Multiplexed immunoassay is the detection of multiple targets in the same
measurement [115,116,154–156]. This can be useful if a disease presents with multi-
ple biomarkers or multiple diseases are being screened [157]. Piraino’s analogue-
digital device was shown to be able to differentiate three different anti-Ebola
IgG strains [88]. Rissin et al. showed the detection of four different proteins,
tumour necrosis factor α (TNF-α), Interleukin - 6 (IL-6), Interleukin - 1α (IL-
1α) and Interleukin - 1β (IL-1β) [158]. These proteins are involved in signalling
within the immune system and can indicate the presence of a multitude of dis-
eases [159]. This was achieved by labelling the beads used during the immunoas-
say so they could be differentiated with fluorescence imaging. This approach
increases the number of detectable species during measurement but multiplies
the minimum detectable concentration during multiplex by the number of tar-












































































































































































































































































































































between 1.2 and 3.9 fM. Individual detection lowered the limit of detection to
0.2 - 0.6 fM. The Simoa HD - 1 analyser is a commercially available multiplex-
ing immunoassay device that has been theorised to be capable of multiplexing
10 proteins at once [160]. Derived from fibre optic well devices previously de-
scribed [126,145,147,160,161], the device contains many of the elements described in
this introduction. Testing has shown the 3-plex systems can be measured but
the reality of 10-plex may not be achieved due to interactions of biological
targets with antibodies and detection molecules meant for other targets. The
footprint of this machine is quite large and is proposed to be a fixed laboratory
item.
The challenges involved with microfluidic immunoassay vary. In static sys-
tems such as mechanically induced arrays or micropatterend surfaces, the size
and geometry of the reaction volume is set before experimentation and may be
difficult to adapt without changing large parts of the devices. Generation of
droplets as reaction vessels through methods such as flow focussing can over-
come this due to the ability to change volume easily. Due to the incubation
times associated with single enzyme reactions being on the order of 10 minutes,
droplets are generated and wasted while measurable signal is being generated.
The rate of generation is large (MHz), a way to take advantage of these droplets
would not only enhance the LOD of a system, but also massively increase the
throughput of measurement. The time for a signal to be present in a droplet
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is so long that methods such as single droplet measurements in flow with a
laser, for example, are not feasible. Storage of droplets in monolithic valve type
structures are easily scaled up, the production of a device with multiple banks
of storage compartments may allow for the utilisation of some of the wasted
droplets.
The detection of cancer biomarkers is common in microfluidic immunoassays
although sometimes consideration is not taken into clinically relevant levels of
these molecules. PSA is a popular cancer biomarker to be measured in these
systems. Usually the motivation calls for monitoring of post prostatectomy
levels as a health human PSA level is 10’s of nM and these assays are, at
their extremes, detecting attomolar concentrations. The development of the
immunoassays to multiplex biomarker detection may not be clinically relevant
for the target biomarkers, but development with a known system is key before
diverging and seeking new molecules to detect [31,106].
1.4 Pressure Drops in Deformable Channels
PDMS is an elastic solid and under pressure driven flow the microchannels it
forms can deform significantly. This behaviour has been used as an advantage in
some microfluidic devices as valves, cell sorting devices, pumps and droplet for-
mation [45,47,102–104,162–165]. The large deformation of channels leads to increased
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surface area and reduced pressure drop throughout the system which can be
overlooked in device design. Efforts to model the flow in collapsible tubes have
been proposed [166], 3D compliant models were developed to study viscous flow
in a compliant tube by applying steady three dimensional Stokes equations to
analyse the flow [167]. Holden et al. observed the bulging of a PDMS channel
through fluorescence microscopy while modifying a theory of convection and dif-
fusion within microfluidic devices originally applied to rigid glass [168]. Hosokawa
et al. developed a device that used a deformable diffraction grating to monitor
the internal pressure of the channel [169]. Cellular and protein shear flow assays
are examples of applications where the actual flow profile is required to infer
shear [170]. Sensing techniques that require known distances such as SPR can
be affected by changes in local geometry [102,171]. The deformation of channels
has been proposed to be a critical parameter in the simulation of blood vessels
for the study of vascular disease [172]. The understanding of pressure induced
deformation can lead to adaptations of devices to match behaviours seen in
vascular systems to model blood flow in compromised biological systems more
accurately.
Gervais et al. performed scaling analysis and computational fluid dynamics
simulations coupled with material deformation models to explain the elastic
deformation of a channel when placed under pressure driven flow [170].
For a rectangular channel, the pressure drop as a function of distance along
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where µ = fluid viscosity, W = channel width and h = channel height [22].
There is a cubic dependence on channel height therefore small changes in
height can lead to significant changes in pressure. In most cases this is advan-
tageous as it allows soft polymer devices to operate at higher flow rates without
the risk of leakage or device breakdown.







In the model, it is assumed that the fourth wall of the device is rigid
(glass) and sealed which provides a zero displacement boundary condition on
the PDMS/glass interface. Above the channel, the PDMS is generally on the
order of 5 mm thick and can therefore be considered a semi infinite medium.
A scaling approximation is used to estimate the deformation experienced by
the channels. Beginning at Hooke’s law ε = σ/E where σ is stress, ε is strain
and E is the material Young’s modulus. Since the stress is proportional to the
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Figure 1.26: Channel cross section normal to flow. Pressure causes an increase
in channel area and reduces resistance.














Lateral deformation can be neglected when W  h and the only surface of
the channel experiencing significant displacement is the ceiling. At any position








Where c1 is a proportionality constant dependant on channel mechanical
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properties as well as geometry. The top wall of the channel is assumed to deflect
in a parabolic manner therefore the channel averaged height is approximately








where h0 is the channel height under no deformation and α=2/3c1. Substi-












The proportionality constant α has not yet been determined for arbitrary
channel geometries. Christov et. al. derived an expression for α which assumes
the deformation of the top wall is smaller than the top wall thickness which
is in turn smaller than the channel width [173]. Other models decompose α for
channel geometries of aspect ratio close to unity [174]
During Gervais’ experimentation it was noted that the deformation was
much greater at the inlet of the device compared to the prediction given by
the theory [170]. This was due to a rapid tapering of the channel before the
measured section causing an unconstrained displacement boundary condition
at that point. It was stated that this effect disappears after a few channel
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widths down the length and therefore will not impact the equation if the first
measurement point is sufficiently far into the device.
Hardy et al. applied the theory devised by Gervais et al. to fluorescence mi-
croscopy images of channels without confocal imaging [172]. The channel height
was inferred from fluorescence intensity of an x-y image of a channel and the
pressure was measured at the same points with pressure transducers. The ac-
quired height measurements agreed with Gervais’ model for deformed channel
heights for devices where the bulk PDMS thickness above the channel was 3
mm. However, when the thickness was reduced to 1.5 mm, the semi-infinite
approximation broke down and the obtained values deviated from the model.
The pressure drop of channels that have thin ceilings on the order of 100 µm
have been investigated by Raj and Christov developing their own models where
the fitting parameter α that was required to be calculated for each geometry is
removed and the model contains no free parameters [173,175]. The derivation of
the new model assumes this top wall as a membrane rather than a plate and
is valid for channels where the width of the channel is greater than the mem-
brane thickness, which in turn is greater than the channel height. During this
thesis the thickness of the bulk PMDS was kept at 5 mm or above so Gervais’
semi-infinite medium approach applies.
The motivations for exploring on-chip pressure measurements start with the
fact that in the literature described, the channel lengths used are generally be-
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Figure 1.27: a) Hardy et al. used a 5 mm long channel of width 500 µm with
5 pressure measurement ports. b) A cross sectional view shows the interfacing
of the straight channel. c) This schematic shows the pressure variation expected
along the channel as a function of distance both on the side plane and across a
cross-section. Figure adapted from Hardy at al. [172].
tween 10 - 50 mm and usually comprise of a straight section of channel, see
figure 1.27. As microfluidic technology continues to develop, the size and com-
plexity of the structures involved are ever increasing and the theories provided
so far in the literature require testing to find if they are suitable to describe
pressure/flow relations in such large devices. Although often overlooked, the
knowledge of pressures built up in microfluidic systems are key when deciding
materials to use for device construction [12]. PDMS is still a very popular and
widely used material for device fabrication and through plasma bonding with
glass can withstand pressures of up to 50 PSI [43]. However, if the proposed
device will exceed these pressures within PDMS, an alternative material may
have to be proposed.
In chapter 4, as well as pressure induced deformation of PDMS, material
transport into bulk PDMS is investigated. As microfluidics is used in a wide
variety of biological applications [1,86,176] it is important to understand how fluids
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within the channels react with their surrounding microfluidic structures. PDMS
is known to allow small molecules to diffuse into the bulk [177,178] with Wang et
al. showing a 90% drop in estrogen concentration after 24 hours incubation
in 40 mm of channel [178]. Due to the fact that cell culture on chip can take
days [97], the loss of these molecules can have a severe impact on the cell growth
and biological processes. The investigation in this thesis looks at the diffusion
of molecules into bulk PDMS and aims to show how this can affect material
properties of PDMS.
1.5 Expansion Microscopy
Expansion microscopy is a relatively new technique that couples the expan-
sion of a hydrogel scaffold with super resolution microscopy techniques [179,180].
The aim of the expansion is to enable the resolution of components within
a sample that could not usually be resolved. The development of expansion
microscopy is described by Chen et al. and involved the use of sodium acry-
late, a component in super-absorbent materials, a co-monomer acrylamide and
a crosslinking agent N-N’-methylenebisacrylamide [181]. The components were
polymerised by the initiation of a free radical reaction using ammonium per-
sulphate (APS) and an accelerator tetramethylethylenediamine (TEMED). A
block of gel polymerised this way experiences a 4.5 fold increase isotropic expan-
55
sion when immersed in water. To image biological sample, a fluorescent anchor
was devised to link the target of interest to the gel matrix. This consists of a
primary antibody followed by an oligo bearing secondary antibody to tag the
biological site. A fluorophore with complimentary oligo strand and methacry-
loyl group anchors the antibody tag to the gel matrix. After this anchoring,
the biological sample is digested away with a buffer so only the anchors remain.
This leaves behind a fluorescent ghost image that is a perfect representation
of the sample that was embedded in the gel. When water is applied, the gel
isotropically expands and the fluorophores move apart in space. This movement
allows for the features to be resolved if this was not possible before expansion.
Chen et al. imaged a brain slice of a mouse and was able to resolve synaptic
interfaces with STORM super resolution microscopy [182]. Tilberg et al. charac-
terised many fluorescent tags for use in expansion microscopy and multiplexed
imaging [183,184] while maintaining the swollen state [185]. A schematic of the first
reported protocol for expansion microscopy is shown in figure 1.28
In the expansion microscopy chapter of this thesis (chapter 5), microfluidic
devices were created to attempt to translate the expansion microscopy protocol
on chip. The subject of the expansion is mouse cardiomyocytes (heart cells).
Dr Jayasinghe (Faculty of Biological Sciences, University of Leeds) is currently
investigating ryanodine receptors in cardiomyocytes which are responsible for
contractions of heart muscle [186]. When the mouse is placed into a heart failure
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Figure 1.28: Schematic of expansion microscopy presented by Tilberg et al.
in Science in 2015. A) i) Schematic of a collapsed hydrogel network comprising
of crosslinker (dot) and polymer chain (line) and ii) expanded network after the
addition of H2O. B) Photograph of a mouse brain slice used in the initial report
of expansion microscopy. C) Post expansion microscopy photograph of the slice
shown in B) (both scale bars in B) and C) = 5 mm). D) The label that is anchored
to the gel at the site of a target biomolecule. E) Schematic of target microtubules
(green) within the polymer network (orange). F) The label D) hybridized to
an oligo-bearing secondary antibody (top grey) bound to a primary antibody
(bottom grey) to target microtubules (purple). The orange dot represents the
link between the label and the polymer network which remains after the cell is
digested. Digestion removes the microtubules as well as the targeting antibodies.
Figure adapted from Chen at al. [181].
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condition, calcium ions (Ca2+) that would usually be released from ryanodine
receptors is decreased. The receptors are present in clusters and are difficult to
image conventionally as the individual units of the cluster can be as low as 40 nm
apart. The use of expansion microscopy enhances the resolution and allows the
clusters to be resolved [187,188]. The acrylamide gel used in expansion microscopy
is fragile, especially in a swollen state due to the high water content [185], so a
proposal for integrating all components of the protocol on chip was created. The
iterations of chip design and issues encountered will be described. The aim of
the project was to lay the foundations of a versatile platform for the expansion
and imaging of various biological samples. If a microfluidic device of tunable
chamber size can be created, the amount of expansion can be tuned. Currently
the standard recipe for expansion microscopy allows for an expansion of 4X
although current innovations are pushing the expansion to 10X and above [189].
1.6 Aims and Motivations of the Project
1.6.1 Single Molecule Detection of the Enzyme β-
galactosidase and Prostate Specific Antigen
Chapter 3 shows the charaterisation of a femtolitre droplet generating device
along with the investigation of single enzyme detection and ELISA of PSA on
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chip. Based on the work of Shim et al. [3], this work intends to expand the
usage of the device proposed in the previous study to enable lower concen-
trations of target biomarker to be detected. To achieve this lower LOD, the
implementation of larger storage areas or the utilisation of wasted droplets was
considered. Larger storage means more droplets can be observed and therefore
lowers LOD. With such high droplet generation rates, many droplets are wasted
while enzyme/substrate reactions are taking place in stored droplets. Although
ultimately not achieved, these issues were the motivation to develop the mi-
crofluidic immunoassay platform. The system uses fluorescence as a detection
mechanism which is becoming cheaper and easier to integrate into microflu-
idic templates [190]. Other methods using Raman spectroscopy, SERS, SPR,
redox detection or micro-QCMD [191] require the use of sensitive and potentially
expensive measurement equipment, whereas fluorescence has the potential to
become cheap and portable and in some cases not requiring a microscope [190].
This could pave the way for the creation of a portable, field-based device based
on current designs.
Also proposed is the multiplexing of biomarker detection within the de-
vice to screen for multiple targets. PSA is used as a model system as it is
well understood within the single molecule immunoassay community as a plat-
form to detect other biomolecules. Currently the detection of PSA at such low
concentrations using these methods may not be completely suitable for diag-
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nostic purposes but the model system can lead to the discovery of potential
new biomolecules of interest. In this chapter it is shown that single molecules
of enzyme are able to be detected but the target biomarker remained elusive.
1.6.2 Pressure Induced Deformation of Channels after
Mineral Oil Absorption
The aims of the investigation during chapter 4 were to develop a method of
measuring pressure on chip without the use of pressure transducers but instead
using a pressurised air supply to equilibrate the flow. The use of PDMS swelling
liquid is investigated and its effect on the pressure characteristics and mechani-
cal properties of the polymer are shown. The understanding of pressure within
a microfluidic device can help to assist in device design where the mechanisms
being integrated onto a chip may cause excess pressure to be present. Building
on current models for relatively short channels (10 - 50 mm) this work will
demonstrate the measurement of pressure within channels of length up to 470
mm and showing that these models do hold for such geometries. The absorp-
tion of molecules into bulk PDMS can be an issue for biological systems on
microfluidic chips as key signalling or stimulant molecules can be lost into the
bulk [192]. Using Raman spectroscopy, it is shown how molecules from a mineral
oil permeate into the bulk and the associated time scales involved. This also
leads to an investigation of how these absorbed molecules induce a mechani-
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cal property change in the PDMS through change of Young’s modulus. This
change then influences the pressure within the channel.
1.6.3 Chip Development for Expansion Microscopy
Imaging of Cardiomyocytes
Chapter 5 shows the developmental stages of a device to capture cardiomyocytes
within an acrylamide gel for the purpose of performing expansion microscopy
on chip. The first four iterations of the device are described and initial exper-
imentation shown. The process of expansion microscopy requires the handling
of delicate hydrogels that are prone to damage during transportation to vari-
ous steps of the protocol. The use of a microfluidic device has been proposed
to enable the protocol to be carried out without the need for such transport,
enabling an easier protocol for such delicate samples. The proposed system
could be scaled to accommodate cells of varying size after characterisation of
the process is completed. As of writing, the cardiomyocyte cells have been suc-
cessfully captured in the acrylamide gel and the future steps involve digesting




This chapter provides an overview of the experimental techniques used in this
thesis. These include microfluidic manufacturing techniques, preparation of
samples for single molecule detection and optical microscopy/spectroscopy tech-
niques.
2.1 Device Design
The device used to perform immunoassay experiments is shown in figure 2.1.
The device is made up of two layers, a layer that contains the two immiscible
fluids that form and transport generated droplets (from here, the flow layer) and
a layer containing valve structures to manipulate the flow directions of fluids
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within the flow layer (from here, the control layer). The flow layer comprises of
channels that are 25 µm in height and 100 µm wide. This device was designed
and used in an article previously published before the work of this thesis [3].
Figure 2.1: The PDMS chip used to perform single enzyme detection/PSA
experiments. The upper layer consists of a nozzle (5 µm high and 10 µm at its
narrowest width), flow channels (25 µm x 100 µm) and droplet storage area (2
mm x 7 mm, 5 µm in height). The control layer contains monolithic microfluidic
valves actuated by pressure to control droplet flow and activate traps. After
generation, droplets can bypass the storage area and leave the device (stream
1) or be diverted with the flow valve into the storage area for trapping and
observation (stream 2).
2.2 Photolithography
The device consists of four fluid injection ports, two for oil and two for aqueous
solutions. The fluids meet at the flow focusing nozzle, shown in figure 2.2. At
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the nozzle, the aqueous solution is sheared against the oil and monodisperse
droplets are formed. The theory describing this droplet production can be
found in section 1.2.
Figure 2.2: The nozzle of the PDMS device where aqueous droplets of diameter
typically 4 µm are generated. Fluid inlets are 25 µm in height and 100 µm in
width before reducing to a height of 5 µm. At its narrowest, the nozzle width is
10 µ wide where the droplets are generated.
After droplet production, the droplets flow through a serpentine mixer (the
function of which is described in section 1.1.2.2) to ensure the reagents are
thoroughly mixed. The control layer of the device is positioned below the flow
layer with a thin 15 µm PDMS membrane. The application of pressure to
these channels causes the flow channel above to become blocked, as described
in section 1.1.2.3.
After mixing, the droplets reach a junction in the channel (shown by the
red arrows in figure 2.1). With no pressure applied in the flow diversion valve,
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the droplets travel down the flow channel and out of the outlet. With pres-
sure applied, the flow is diverted into the droplet storage area. Upon entering
this area, the channel height reduces to 5 µm and the droplets spread into a
monolayer. The application of pressure into the trap valve causes 40 square
traps to rise, confining the droplets. Trapped droplets can be released after
measurement by removing the pressure, causing the droplets to flow out of the
device and be replaced by freshly generated samples.
The first step in creating the microfluidic device was to design the device
layout through a computer aided design (CAD) program such as AutoCAD
(Autodesk). This design was then transferred onto a substrate through a pho-
tolithography process. A microfluidic master was created through lithography
of SU-8 photoresist (MicroChem), a photosensitive material that is selectively
exposed to UV light to cause crosslinking of desired patterns. The mechanism of
SU-8 crosslinking begins with UV exposure. The UV activates triarylsulfonium
salts to produce an acid which acts as a catalyst for the epoxy crosslinking of
SU-8 [193]. This epoxy crosslinking occurs during the post exposure bake [40,194].
3 inch silicon wafers (Pi-KEM) were cleaned with acetone followed by iso-
propanol, after which they were baked in an oven at 150 ◦C for 15 minutes
to dry. SU-8 photoresist (from here referred to as resist) was deposited onto
the wafer by spin coating where the speed of spinning determines the resulting
thickness [193]. Devices used in this thesis had features that varied from 5 - 25
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µm in height. These heights were measured using a Dektak XT surface profiler
(Bruker), a stylus-based profilometer instrument after lithography was com-
pleted. To achieve these heights, 2 different varieties of SU-8 were used: SU-8
2005 (less viscous therefore thinner film thickness) for the 5 µm features and
SU-8 2025 for the 25 µm. After spin coating, the wafer was baked by ramping
the temperature of the wafer on a hot plate from room temperature to 55 ◦C,
held for 30 minutes and then brought back down to room temperature. This
temperature ramp reduced thermal stress within the resist film and prevents
wrinkling. The purpose of this bake was to reduce the solvent concentration
within the SU-8 and partially cure the film.
After the resist has been baked, there were two methods of UV exposure.
The resist can be exposed using a UV lamp to flood the wafer with light of
the correct wavelength while a mask containing the device design blocks areas
outside of the design. SU-8 is most sensitive to 365 nm UV light which is
usually emitted by a mercury lamp. Mercury lamps emit high intensity light at 3
spectral points that are useful for photolithography, 365 nm, 405 nm and 436 nm
(these are know as the i-line, h-line and g-line respectively [195]). The masks used
were printed on plastic transparencies of size A4 containing six 3 inch designs.
This process takes place on a mask aligner (Model 200, OAI). The second
method of exposure, the Direct Writing Laser (DWL) system (Microwriter 2,
Durham Magneto Optics), uses a 375 nm laser to effectively draw the design.
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This method removes the need for a mask as the machine only requires the
CAD file as an input but increases the time of exposure from a few seconds to
many hours. More complex device designs can take from 18-24 hours to expose.
An advantage of the DWL system is that it is possible to quickly adjust designs
without the need to order new masks at high cost.
For exposure using a mask, the following protocol was used. The baked
wafer was placed on a vacuum stage after which the mask containing the re-
quired design was placed on top of the wafer. The wafer and mask were brought
into contact with a piece of glass to provide tight contact. The mask and wafer
were then exposed to UV light from a lamp filtered to provide 365 nm UV.
Exposure time of the wafer depends on the thickness of the resist, 25 µm films
require 150 mJ/cm2 whereas 5 µm films require 100 mJ/cm2.
Using the DWL system, the wafer is placed on a vacuum stage within the
machine. The laser is then focused on the wafer surface before the design file is
uploaded. The laser is of wavelength 375 nm so the exposure energy must be
increased for similar exposure to the mask aligner. For example, for a 25 µm
film, an exposure energy of 300 mJ/cm2 was used. The DWL has resolution
options ranging from “Fastest” to “Highest” that can be adjusted depending on
the X-Y resolution of the features. A channel of width 100 µm can be exposed
on “Fastest” with no degradation of the feature, however smaller features such
as 10 µm flow-focusing nozzles must be exposed on “Highest”. The DWL will
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then perform a focus lock measurement, which can detect variations in the
surface height of the resist ensuring consistent focus throughout the exposure.
The laser then rasters in the X-axis, selectively exposing the resist where the
design file dictates.
After exposure, regardless of method, the wafer was baked using the same
protocol as the soft bake. This post exposure bake (PEB) enhances the photo-
initiated crosslinking of the resist. The wafer was then developed in a solution
of EC Solvent (ethyl lactate, MicroChem) which removed the areas of resist that
had not been exposed revealing the desired pattern on the wafer. Depending on
the feature size/exposure conditions, the resist may show some surface cracks.
In order to anneal these, the wafer was placed in an oven at 210 ◦C for 30
minutes (hard bake).
After height verification using the Dektak XT, the wafer was coated with
trimethylchlorosilane to assist in de-moulding PDMS in the soft lithography
process. The master was then used in the soft lithography process.
2.3 Multilayered Devices
If the device requires multiple heights in the design, multiple layers of resist
were used. The photolithography process remains the same except that after
the development of the first layer, a second layer was spin coated onto the
68
Figure 2.3: Schematic of master fabrication using SU-8. a) Su-8 is spin coated
on silicon before being baked b). The wafer is then exposed to UV light by
c) Mask aligner or d) DWL. e) After a hard bake the wafer is submerged in
ethyl lactate solvent to dissolve unexposed resist. f) The wafer is ready for soft
lithography.
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wafer. After the soft bake the layers must be aligned, the method of which
depends on the exposure technique. When using the mask aligner, the mask of
the second layer remains stationary while the wafer was moved on the vacuum
stage using micrometers to align with alignment marks on the wafer and on
the mask. Using the DWL, marker points were defined using the coordinate
system of the design file to correct for X-Y displacement as well as rotation.
After exposure of the second layer, the process was the same as for single layer
wafers.
2.4 Soft Lithography
For single layer devices, PDMS monomer was mixed thoroughly with crosslinker
at a 10:1 ratio (Sylgard 184 elastomer kit, DOWSIL). The mix was centrifuged
at 4000 RPM for 1 minute to remove bubbles formed during mixing. The cleared
solution was poured over the master wafer inside a 90 mm petri dish to a height
of 5 mm. The wafer was placed in a vacuum desiccator to remove any further
bubbles before baking in an oven at 75 ◦C for 30 minutes. The now solid PDMS
was cut from the wafer revealing channel patterns. Fluid inlet and outlet holes
were punched using 1 mm biopsy punches (Kai Medical) and gas inlets punched
with 0.573 mm outer diameter (23 American Wire Gauge (AWG)) needles to
interface with tubing (interfacing with the device is explained in section 2.8.
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At this point the channels were 3 sided and require sealing. The devices and
glass slides were placed in an oxygen plasma generator (Femto low-pressure
plasme cleaner, Diener) for 2 minutes, which reacts with the surface of both
components converting -Si-CH3 groups to -Si-O-H. When brought into contact,
the surfaces covalently (therefore irreversibly) bond through a condensation re-
action forming Si-O-Si bridges between the layers with H2O as a byproduct
[42].
The completed devices were baked at 75 ◦C for 30 minutes before use. Ex-
periments in chapter 4 where the modulus of the PDMS should be controlled,
all baking times were 30 minutes and the devices were used in experiments
immediately to avoid changes in modulus through further baking. Devices for
immunoassay experiments were left in an oven at 75 ◦C until required and were
fully functional after multiple days in the oven.
For multi-layered devices, the first layer (top) was manufactured in the same
was as described until the inlets/outlet had been punched. The second layer
(bottom) was made by spin coating PDMS onto the master wafer at a height
usually 15 µm higher than the height of the SU-8 features. This was achieved by
spinning 10:1 PDMS/Crosslinker according to the spin curves shown in figure
2.5. The wafers were left to settle for up to 90 minutes at room temperature
to smooth the PDMS before being baked at 95 ◦C for 10 minutes on a hot
plate. The two layers were then aligned and bonded together after 2 minutes of
oxygen plasma exposure and baked for 30 minutes at 75 ◦C. This alignment was
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done by hand and appropriate design features were included to allow the device
to function even if the alignment was not perfect. After baking, the two-layer
PDMS was peeled off the wafer and inlets were injected for the second layer.
This device was then bonded to glass using the same protocol as described
above.
Using the soft lithography protocol, it was possible to produce 2 sets of
single layered devices or 1 set of double layer devices per day. Depending on
the size of designs, this resulted in between 4 and 20 devices.
2.5 Device surface modification - Aquapel
In order to assist the production of femtolitre sized droplets, the flow fo-
cusing nozzle of the device was coated to make it hydrophobic. This was
achieved by injecting Aquapel (Pittsburgh Glass Works LLC), a car wind-
screen hydrophobic treatment, the main component of which is 1H,1H,2H,2H-
Perfluorodecyltriethoxysilane. This was injected through an oil inlet until it
reached the nozzle, ensuring it did not progress into the water channels. After
application, the device was placed in a 75 ◦C oven for 30 minutes to dry.
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Figure 2.4: Schematic of soft lithography of PDMS devices. 1) Liquid PDMS
was poured onto the master wafer mould and degassed. After a 30 minute bake
at 75◦C the PDMS was cut and peeled from the wafer 2). Inlet and outlet ports
were punched with biopsy punches 3). For a single layer device A) the PDMS
exposed to oxygen plasma to functionalise for covalent bonding to glass Ai) If the
device was multilayered and incorporated valves B), a thin layer of PDMS 15 µm
higher than the valve channel height was spin coated onto the wafer Bi). This
was baked before oxygen plasma treatment and alignment with the flow channels
previously fabricated. Both sets of channels were removed from the wafer, inlets
punched for the valves and bonded to glass Bii).
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Figure 2.5: PDMS spin curve for a 10:1 ratio of PDMS base to crosslinker for
a spin time of 20 and 60 s. PDMS was spread with a spin of 800 RPM for 5
seconds before spinning up to final speed
Figure 2.6: Aquapel - 1H,1H,2H,2H-Perfluorodecyltriethoxysilane. The injec-
tion of Aquapel into a flow focussing nozzle increases hydrophobicity.
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2.6 Bead-Antibody Conjugation Protocol
Amino functionalised beads that are 1 µm in diameter were coupled to anti-PSA
antibodies using a commercially available kit (Polysciences). PBS was prepared
by dissolving one 5 g tablet of PBS powder in 500 ml of MilliQ water (pH 7.45,
140 mM NaCl, 10 mM PO 4 , 2.68 mM KCl). PBS was filtered through a 200 nm
cellulose membrane syringe filter (Minisart RC4, Sartorius Stedim, UK) prior
to use. Firstly, 0.129 ml of 2.5% bead solution (77pM) was mixed with 0.071
ml of PBS buffer containing 0.5% Tween-20 (Sigma). This resulted in a 50 pM
bead solution. The beads then underwent a washing step involving centrifuging
the bead solution for 6 minutes in a microcentrifuge at 13 kRPM then careful
removal of the supernatant. The remaining pellet was then resuspended in
300 µl of PBS containing 0.5% Tween-20 via sonication for 3 minutes. After
these centrifugation and sonication steps were carried out 3 times, the pellet
was resuspended in 200 µl of PBS with Tween-20. 400 µl of 8% gluteraldehyde
was added, which bonds to the primary amine groups on the beads. This
solution was sonicated for 1 hour and shaken for 4 hours to ensure a complete
reaction. The beads were then washed 3 times using the method described
previously. 125µl of PBS and 75µl of capture antibody (monoclonal anti-PSA,
R&D Systems) were added to resuspend the pellet. The resulting solution
is composed of 50 pM bead and 200 µg/ml of capture antibody. Overnight
incubation on a shaker ensures all of the gluteraldehyde molecules bond to
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the primary amine groups on the antibodies. There are 4 possible binding
sites of the gluteraldehyde due to the antibody being comprised of 4 monomers
which bind via the N-terminus. After overnight mixing, the solution was again
centrifuged and the supernatent collected. This supernatent was then analysed
by UV-vis to determine the amount of protein in the solution. This value
indicates how much of the protein remains and, therefore, how much has bound
to the beads. The pellet was then resuspended in 500 µl of 0.2M ethanolmine
and mixed for 1 hour. This step blocked any unreacted gluteraldehyde sites
on the bead. The solution was centrifuged and resuspended in 500µl of 0.1 %
Bovine Serum Albumin (BSA). BSA was used to block any nonspecific protein
binding sites on the bead that would affect the binding of PSA to antibody in
later steps. A final centrifugation for 6 minutes at 13 kRPM followed by the
addition of 200µl of a storage buffer (PBS + 1 % BSA + 0.1 % sodium azide)
completes the bead-antibody conjugation.
2.7 Immunocomplex Formation Protocol
Formation of the immunocomplex is shown in scematic figure 2.7. The next
component of the immunocomplex was the target biomarker. The biomarker
bonds to the antibody through weak chemical interactions on one of two active
sites. To add this to the complex, 40 µl of the antibody conjugated beads was
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added to 160 µl of PBS with 0.5 % Tween-20 resulting in a 10 pM solution.
The beads were washed 3 times using the same method as previously described.
The resulting pellet was suspended in 100 µl of PBS with 0.5 % Tween-20 and
100 µl of target biomarker added in a number of given concentrations as well as
a control with no biomarker (PSA biomarker, 30 kDa, R&D Systems). The so-
lution was incubated for 2 hours then washed twice. After biomarker binding a
biotinylated detection antibody (polyclonal anti-PSA, R&D Systems) was con-
jugated. The solution from the previous step was centrifuged and supernatent
removed. The pellet was resuspended in 100 µl of PBS with 0.5 % Tween-20
and 100 µl of 17 nM detection antibody. This was incubated for 1 hour and
washed 6 times. The resulting pellet was resuspended in 200 µl of PBS with
0.5 % Tween-20 giving a solution of 10 pM bead and 8.5 nM detection anti-
body. The final component of the immunocomplex is streptavidin conjugated
β-galactosidase (Invitrogen). After again being centrifuged, the pellet was sus-
pended in 100 µl of PBS with 0.5 % Tween-20 and 100 µl of 50 nM streptavidin
conjugated β-galactosidase. The solution was incubated for 1 hour before being
washed 6 times. The sample was sonicated for 30 minutes and then injected





























































































































































































































































































2.8 Fluid Delivery - Pumps, Tubing, Interfac-
ing with devices
In this thesis, microfluidic devices required liquid delivery and pressurised gas
to operate all of the components. Liquid delivery was performed with syringe
drivers, (Harvard PhD ULTRA) in either single or dual gang mode. The size
and material of the syringes will be given in their corresponding experimental
descriptions.
Polythene tubing 0.36 mm inner diameter and 1.09 mm outer diameter
(Smiths Medical) was interfaced with devices by direct insertion into the
punched inlets/outlets. Gas inlets were interfaced with Tygon R© polymer tubing
with a 23 american wire gauge metal insert. In devices where the connections
experience high pressures, the tubing was sealed to the device with Norland
optical adhesive (NOA-81, Norland Products). This adhesive was applied to
the connection and cured under a 365 nm, 120 W UV lamp for 10 minutes.
This provides a good seal against leakage without the adhesive being brittle.
The adhesive also exhibits low auto fluorescence which will not interfere with
fluorescence microscopy imaging [196].
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2.9 Pressure Control System
A 95 PSI air supply was directed into 4 pressure regulators, 2 x 0-30 PSI and
2 x 0-120 PSI (March Bellofram Precision Regulator, type 10) before being
connected to valve banks to actuate the supply. These valve banks connected
to the Tygon R© tubing described above.
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Figure 2.8: The device used in this study comprised of 250 µm wide by 21 µm
deep channels. At 50 mm intervals, pressure measurement points are connected
to a regulated air supply. A schematic of the device setup showing the fluid inlet
and 4 pressure measurement ports.
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2.10 Camera & Software
Fluorescence images were acquired using a Andor iXon EMCCD camera
through Micro-Manager 3 software. During pressure experiments, bright field




In epi-fluorescent microscopy, a sample is illuminated with a narrow spectral
band leading to emission at a shifted spectral band. These microscopes use
mercury bulbs to produce a wide spectral light source. An excitation filter is
placed in the path of the light source to select the excitation wavelengths of the
sample required. The beam is then directed to the sample through reflection
off a dichoric mirror where the excited state of the sample relaxes to produce
a fluorescence which is observed as a shift in wavelength in emitted light. This
fluorescence then travels through the dichoric mirror and onto a detector.
During fluorescence measurements, a Bioimager BIM800FLW inverted epi-
fluorescence microscope was used. A mercury lamp was used as the light source
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and the microscope was fitted with an FITC filter set (excitation 475 ± 35 nm,
Dichoric mirror 508 nm and emission 530 ± 43 nm) and a Texas Red filter
(excitation = 559 nm, emission = 630 nm).
Figure 2.9: Schematic of an upright fluorescence microscope. An excitation
filter is used to select the wavelength to illuminate the specimen. A dichoric
mirror directs the beam to the sample and allows the emitted wavelength through
to a detector after an emission filter.
2.11.2 Fluorescence Spectroscopy
During enzyme kinetics studies fluorescence spectroscopy was performed with a
Perkin-Elmer LS 55 fluorescence spectrophotometer. This method uses a xenon
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lamp to produce excitation light at wavelengths from 250-790 nm. Monochro-
mators within the spectrometer select the excitation and emission wavelengths
during data acquisition which is detected through photomultiplier tubes. The
sample was loaded in a 1.5 ml quartz cuvette with path length 1 cm.
2.11.3 UV/Vis Spectroscopy
Ultraviolet-visible spectroscopy (UV/Vis) measures the absorption of a sample
after excitation from an ultraviolet/visible wavelength source. The ratio of
incident light intensity to the intensity received by a detector provides the
absorption. The light source travels through monochromators to select the
excitation wavelength incident on the sample. The absorbance of the sample
follows Beer-Lambert’s law shown in equation 2.1 where A is the measured
absorbance, I0 is the incident light intensity, I is the transmitted intensity, ε
is the extinction coefficient, c is the concentration of the sample and L is the
path length through the sample. The extinction coefficient ε is a property of
the molecule being measured and has units of M−1cm−1. Samples were loaded







Uv/Vis spectroscopy can be used to determine the concentration of protein
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in a sample through absorption at 280 nm due to the presence of the amino
acid Tryptophan. Tryptophan contains aromatic rings causing delocalisation of
electrons in the Π–orbital. This causes a large absorption at 280 nm, the inten-
sity of which is indicative of the protein concentration [197]. This method was
used to determine protein concentration before and after antibody conjugation
onto amine functionalised beads described in the bead-antibody conjugation
protocol. The extinction coefficient for a typical IgG antibody with molecular
weight 150 kDa is 210,000 M−1cm−1 due to the presence of 11 Tryptophan
amino acids in the heavy and light chain [197]. Uv/Vis spectroscopy was per-
formed on a Agilent Cary 5000 Uv-Vis-NIR spectrophotometer.
2.11.4 Raman Spectroscopy
Raman spectroscopy uses the principle of Raman scattering to collect molecular
information about a sample. When light is incident upon a sample most of the
photons will scatter with unchanged energy (Rayleigh scattering), however, ap-
proximately 1 in 106 photons will interact with the molecular vibrational states
of the sample and experience an energy shift. This differs from fluorescence
as there is no emission of a photon from an excited state relaxing to a ground
state. There can be a loss in energy, known as Stokes Raman scattering, or
an increase in energy, anti-Stokes Raman scattering. This energy change is
dependent on the vibrational frequency of the molecules’ bonds and their po-
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larisability and as such, the measured energy shift provides information on
molecular structure. When measuring Raman signal, the sample is illuminated
with a monochromatic light source such as a laser. The Rayleigh scattered
photons are filtered out before the detection of Raman scattered photons. The
intensity of detected photons is plotted against wavenumber to produce a Ra-
man spectra. The wavenumber is the shift in energy through the interactions
with the molecule and its calculation is shown in equation 2.2 where ∆w is the
wavenumber, λ0 is the excitation wavelength and λR is the Raman scattered
wavelength. Displaying the energy shift as opposed to raw photon wavelengths
allows comparisons of data even if taken at different excitation wavelengths.
These peaks in the Raman spectra are distinctive to molecules and a spectra
can be considered a molecular fingerprint. Figure 2.10 shows the changes in







For measurement of mineral oil diffusion into PDMS, devices were prepared
on 60 x 24 mm glass coverslips of # 1 thickness (130 - 160 µm). The Raman
system used was an inVia Raman confocal inverted microscope (Renishaw)
with a Leica DMi8/SP8 laser scanning confocal microscopy system with 532
nm, 22 mW laser. The system was calibrated with the 532 nm laser using a
silicon calibration sample with expected peak at 520.5 cm−1. Raman spectra
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were taken of pure mineral oil, pure PDMS and an empty channel to identify
characteristic peaks. A scan line of length 1 mm was positioned so that it
began in the empty channel and ended within the bulk PDMS. Along this line,
spectra were taken every 20 µm with an acquisition time of 1 s. After this scan
the injection of mineral oil was started and spectra taken along the scan line
every 5 minutes for 90 minutes.
Figure 2.10: Schematic illustration of Rayleigh scattering as well as Stokes
and anti-Stokes Raman scattering. νL represents the energy of the excitation
laser which is much greater than the molecular vibrational energy. νm represents
the vibrational energy of the molecule which is added to (anti-Stokes scattering)
or subtracted (Stokes scattering) from the energy of the incident laser photon.
When no interaction with the molecular vibrational modes occurs, Rayleigh scat-
tering takes place.
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2.11.5 Confocal Laser Scanning Microscopy
Confocal laser scanning microscopy is a technique for imaging samples with
a shallow depth of field. The microscope is advantageous over conventional
optical microscopy in that out of focus light is removed from the image with a
pinhole resulting in sharp focus at the focal plane. Using a micron resolution
z-stage, multiple images can be taken through a sample and reconstructed into
a three dimensional image. A Leica TCS SP8 on a DMi8 microscope was used
to take confocal fluorescence images of PDMS microchannels containing a 1
µM solution of fluorescein. The microscope was equipped with 488 nm, 532 nm
and 638 nm lasers of which the 488 nm and 532 nm lasers were used to image
fluorescein and Nile Red respectively. Channels were mounted on 60 x 22 mm,
#1 thickness glass coverslips and imaged through a 40X objective. The laser
rastered across the channel at a rate of 400 lines per second at a resolution of
3520 x 100 pixels. Z -stacks were taken with a z-step size of 0.53 µm from the
middle of the glass coverslip until the full channel profile was imaged.
2.12 AFM Modulus Measurements
Modulus measurements were performed on a FastScan AFM (Bruker). During
nanoindentation, an AFM probe is pressed into the surface of a material as the
applied force and tip displacement are measured. The force displacement curve
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provides a highly sensitive measurement of the probe/sample contact stiffness
from which the modulus can be calculated.
The interaction of the tip and sample depend on the tip geometry and the
main models are the Hertz (spherical indenter) and Sneddon (conical indenter)












where F = force (N), E = Young’s modulus (Pa), ν = Poission Ratio (0.5
for PDMS [203]), R = tip radius (m) and γ = indentation.







where α is the half angle of the indentor.
Measurements were taken using a Bruker Sharp Nitride Lever (SNL) tip with
spring constant 0.07 N/m and tip radius of 2 nm and was calibrated using a
silicon sample of known modulus. PDMS was prepared using the standard pro-
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tocol described in section 2.4 at a 10:1 ratio of base monomer and crosslinker.
During experiments, two samples were measured, the first being PDMS pre-
pared as standard and the second having been soaked in mineral oil for 4 hours
before measurement. Young’s modulus values were calculated by fitting the
Sneddon model to force-displacement curves using Bruker NanoScope software.
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Chapter 3
Single Molecule Detection of the
Enzyme β-galactosidase and
Prostate Specific Antigen
This chapter will introduce and describe the experiments to detect single
molecules of the cancer biomarker, PSA using a microfluidic device. The chap-
ter will begin with experiments to measure activity of the detection enzyme
β-galactosidase in bulk conditions through an enzyme kinetics study. The ex-
periments to detect single molecules of β-galactosidase in micron width droplets
will be presented along with characterisation of the droplet production process.
The characterisation of immunocomplex formation for the detection of PSA will
be shown followed by droplet based ELISA experiments. Finally, the results
will be concluded.
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3.1 Enzyme Kinetics Study
3.1.1 Objectives
The objective of this experiment is to determine the activity of the detection
enzyme β-galactosidase. This will be shown through a kinetics study deducing
the number of molecules digested per second (turnover number). The turnover
number estimates the concentration of fluorescent product present in a droplet
during single molecule detection experiments Fluorescence spectroscopy data
will be shown detailing the reaction between the enzyme β-galactosidase and
substrate FDG (Fluorescein di(β-D-galactopyranoside)), figure 3.1a. Analysis
and deduction of key values will be presented.
(a) FDG - Substrate (b) Fluorescein - Observable Product
Figure 3.1: The FDG substrate (a) is digested by β-galactosidase, which forms
Fluorescein (b) and galactose.
The activity of β-galactosidase can be measured by observing the rate of
reaction between the enzyme and substrate. This reaction can be characterised
using Michaelis-Menten kinetics, which is a model of enzyme/substrate reac-
tions.
The reaction between an enzyme can be modelled using equation 3.1 [86].
E + S 
 ES→ E + P (3.1)
Where E=Enzyme, S=Substrate, ES=Enzyme/substrate complex and
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P=Product.





The Michaelis-Menten equation relates the reaction rate, v, to substrate
concentration, [S]. This can also be expressed in terms of the reactions maxi-
mum rate, Vmax, substrate concentration, [S], and the Michaelis Constant, KM
(equation 3.3). The Michaelis constant represents the substrate concentration








kcat is the turnover rate, which is the number of substrate molecules con-
verted to product per enzyme active site per time.
3.1.2 Fluorescein Excitation and Emission Spectra
The excitation and emission of the fluorescein product were measured using a
fluorescence spectrophotometer.
50pM β-galactosidase was mixed with 50nM FDG in a 1:1 ratio in a quartz
cuvette. The solution was incubated at room temperature overnight to ensure
full conversion from FDG to fluorescein.
The spectra in figure 3.2 show peak excitation and emission wavelengths of
484 nm & 514 nm respectively. These wavelengths were used as excitation and
emission during the remaining experiments.
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Figure 3.2: Excitation and emission spectra for a solution of 50pM β-
galactosidase and 50nM FDG incubated overnight for full FDG to fluorescein
digestion. Peak excitation is at 484 nm and peak emission at 514 nm.
3.1.3 Spectrophotometer Saturation
To determine the concentration boundaries of the β-galactosidase/FDG reac-
tion, fluorescein solutions were prepared to be measured using the spectropho-
tometer. A stock solution was prepared by dissolving 3.32 mg of fluorescein
powder in 25 µl of DMSO (Dimethyl sulfoxide). Once dissolved, the solution
was made up to 10 ml with MilliQ (18 MΩcm H2O). The resulting concentra-
tion of fluorescein was 1 mM. This stock was then diluted into 1 ml samples
of fluorescein concentration 1-60 nM for measurement on the spectrophotome-
ter. The solutions were placed in 1.5 ml quartz cuvettes and emission spectra
taken with excitation at 484 nm with emission scan range 500-580 nm. The
concentration limits of the instrument were found to be between 1nM & 60nM
of fluorescein (Figure 3.3).
The intensity of fluorescence at peak emission (514 nm) was plotted against
fluorescein concentration (figure 3.4) yields a gradient of 18.9 ± 0.3 A.U/nM.
This can be used to directly convert fluorescence intensity signal into fluorescein
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Figure 3.3: Emission spectra for increasing concentrations of fluorescein solu-
tion. Excitation wavelength = 484 nm, emission scan range = 500-580 nm. A 60
nM solution causes the instrument to saturate.
concentrations.
3.1.4 β-galactosidase/FDG Reaction Kinetics
Observing the fluorescence intensity at 514 nm over time shows the increase
in fluorescein product during the β-galactosidase/FDG reaction. To monitor
the reaction, 400 µl of 50 nM FDG was added to a quartz cuvette in the
spectrophotometer. 400 µl of 250pM β-galactosidase was added to the cuvette
and mixed thoroughly through pipetting. The instrument was set to measure
the emission spectrum (between 500-580 nm) of the sample with an excitation
of 484 nm, every minute. As the reaction continues, the reaction rate slows as
the available substrate decreases, shown by a decrease in gradient in figure 3.5.
This reaction was repeated with substrate concentrations from 0.5 µM to
500 µM FDG. A profile of fluorescence vs time was measured and the reaction
rate was calculated for each substrate concentration. The reaction rate of each
was then plotted against the substrate concentration, a Michaelis-Menten curve
(figure 3.6). The curve was fitted with a Hill function to output the maximum
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Figure 3.4: The fluorescence intensity at 514 nm increases linearly with fluores-
cein concentration. The spectrophotometer saturates above 50nM. This plot also
gives a direct conversion factor between fluorescent intensity and concentration
(18.9 ± 0.3 A.U/nM). Error bars too small to be plotted, n = 3.
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Figure 3.5: Fluorescence intensity of the β-galactosidase/FDG reaction mea-
sured at 514 nm in intervals of 1 minute for 70 minutes displays the full reaction.
The initial slope of the reaction is the reaction rate (v). Single reaction plotted.
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velocity, Vmax, and Michaelis constant, KM .
Figure 3.6: The Michaelis-Menten curve of the β-galactosidase/FDG reaction
shows the rate of reaction saturating as the substrate concentration increases.
For each point, the reaction rate was extracted from an enzyme reaction profile
as shown in figure 3.5. n = 3
To extract the KM and Vmax values, a Lineweaver-Burke plot was produced
(figure 3.7). The Lineweaver-Burke equation (equation 3.4) takes the inverse
of the Michaelis-Menten equation (equation 3.3). The values of inverse velocity
were plotted against inverse substrate concentration (figure 3.7) and produced
a straight line of gradient = KM
Vmax

















From the Lineweaver-Burke fit (figure 3.7), Vmax = 173± 40 A.U/min and
KM = 137± 30µM
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Figure 3.7: Linewaver-Burke Plot of the β-galactosidase/FDG reaction. Y-
intercept= 1Vmax and gradient=
KM
Vmax
. Vmax = 173 ± 40 A.U/min and KM =
137± 30µM . n = 3
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To obtain the turnover number, the maximum velocity, Vmax, is divided by
the β-galactosidase concentration. kcat = 13700 ± 700s−1. This corresponds
to 13700 molecules of FDG converted to molecules of fluorescein product per
second. In a droplet based single molecule detection experiment, inside droplets
of diameter 4 µm, the fluorescein concentration will be 24 ± 1µM after 10
minutes of incubation.
3.1.5 Summary
The kinetics of the reaction between enzyme β-galactosidase and substrate FDG
have been shown. The literature reports KM values of the β-galactosidase/FDG
reaction to be anywhere from 18 - 638 µM [205,206]. The experiment which deter-
mined a value of 638 µM [206] was performed under the same conditions as Huang
et al. (18 µM [205]) and commented that such a low result was unusual and de-
termined under ”erroneous assumptions” although these assumptions were not
stated. A study by Rissin et al. whereby single enzyme molecules were trapped
in a fibre optic array calculated the KM value of the bulk β-galactosidase/FDG
reaction to be 117 ± 23 µM which overlaps with the values obtained in this
study of 137 ± 30 [207].
3.2 Droplet Production
3.2.1 Objectives
This section will show experiments performed to investigate droplet production
in a flow-focusing microfluidic nozzle. The geometry of the nozzle was modified
and droplet generation observed. A description of the manufacturing process
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to produce the nozzles will be given, after which measurements of droplet di-
ameters as a function of oil flow rate will be shown. Analysis and conclusions
will follow. The experiments of droplet production were performed using the
immunoassay device described in section 2.1.
Monodisperse droplet production is a key feature in the biomarker detection
experiments. The monodispersity of the droplets provides identical reaction
vessels for the formation of detectable product through the enzyme-substrate
reaction. Inconsistencies in droplet size lead to changing effective product con-
centrations, which can make droplets appear less fluorescent and therefore can
be interpreted as not containing biomarker.
The aim of this section is to determine the flow parameters required to
produce 4 µm diameter droplets in the flow focusing nozzle.
The diameter of droplets generated through a flow-focusing nozzle, D, is
given in equation 3.5 from Yobas et al. [208], where Ca = capillary number, σ
= interfacial surface tension, r = radius of curvature at the droplet production








In order to investigate droplet generation in flow-focusing nozzles, the chip to
perform the single molecule immunoassay experiments was used. The geometry
of the nozzle was changed by manipulating the diameter of the droplet produc-
tion orifice (shown by the red arrow in figure 3.8) and new devices created using
the DWL lithography system.
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Figure 3.8: The flow focusing nozzle that is being investigated. Two continuous
oil inlets shear the aqueous phase. The red arrow indicates the droplet production
constriction that is being modified.
SU-8 2005 photoresist (Microchem) was spin coated onto a 3” Silicon wafer
at a thickness of 5 µm and baked. After baking, the wafer was placed in the
DWL where a 365 nm laser rastered across the surface and selectively exposed
the photoresist. After another baking step, the resist was developed and the
nozzle pattern remained.
The lithography process was repeated again for the larger channels of depth
25 µm this time using SU-8 2025 photoresist. Verification of the resist thickness
was measured using a Dektax XT surface profiler. This is a stylus-based step
measurement instrument, which can scan profiles of length 10 mm. Maximum
step size is 1000 µm and the vertical resolution of the stylus is ∼ 0.3 Å. The
average SU-8 2005 height measured was 4.2 ± 0.2 µm & the SU-8 2025 had
average height of 22.17±0.1µm.
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Figure 3.9: 3D mapping of SU-8 height with the Dektak XT shows the geo-
metric constriction during droplet generation.
3.2.3 Experimental Methods
The droplet generation experiment was performed using PBS buffer (pH 7.4) as
the aqueous phase and fluorinated oil (HFE 7500, Novec, 3M) as the oil phase.
Droplets were stabilised with a block-co-polymer surfactant dissolved in the oil
phase (5% w/w). A schematic of the droplet generation is shown in figure 3.11
Each solution (oil and buffer) was injected into the microfluidic device using
Hamilton 2500 µl (Oil) and 250 µl (buffer) syringes driven by a syringe driver
(Harvard Apparatus PHD 2000). Polyethylene tubing (Smith Medical) of inner
diameter 0.36 mm and outer diameter 1.09 mm was used to interface with the
microfluidc device.
During the experiment, the PBS buffer was kept constant at a flow rate of
40 µl/h. The oil flow rate was increased and the droplets were imaged at the
outlet of the device. Diameters of the droplets were measured using ImageJ
software.
Figure 3.10 shows the diameter change of droplets produced with varying
oil flow rates. Droplet size is inversely proportional to the oil flow rate QO. The
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geometric constriction allowed for large shear forces to be produced within the
device. This generates high frequency small droplets down to 4 µm. The use of
a block co-polymer surfactant reduced the interfacial tension of the two phases
and the use of a low viscosity oil (around 1.2 cP) enabled the chip to overcome
high hydrodynamic resistances that are experienced with more viscous oils [21].
Silicon oil at around 19 cP and mineral oil at 123 cP would not allow stable
femtolitre sized droplets to be produced [3].
Figure 3.10: Generation of droplets was performed using a 5 µm high by 6
or 10 µm wide flow focussing nozzle. HFE 7500 oil with 0.5% block copolymer
surfactant was the continuous phase with PBS buffer as the discontinuous phase.
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Figure 3.11: Droplet diameters decrease at a rate inversely proportional to the
oil flow rate. In the 6 µm nozzle, the droplet production became unstable above
QO = 320 µl/h. n = approx. 350 droplets per point.
3.2.4 Summary
From this data, it can be concluded is that it is possible to produce 4 µm
droplets in a flow focusing nozzle where the constriction geometry is 10 x 5 µm
and 6 x 5 µm
3.3 Single Enzyme Detection
The β-galactosidase/fluorescein di-β-galactopyranoside (FDG) reaction (see
section 3.1) is the reporting element of the single molecule immunoassay. The β-
galactosidase enzyme is the final component of the bead-based immunocomplex
and its reaction with FDG shows the presence of target biomarker. Showing
the viability of this reaction within droplets is key to single molecule detection.
105
3.3.1 Pure Fluorescein Detection
Droplets of fluorescein were produced in the microfluidic device to ensure de-
tection was possible. The concentration of fluorescein solution prepared was
between 5 and 20 µM. Each concentration of fluorescein was injected into the
microfluidic device in the aqueous phase inlets. Droplets were formed in the flow
focusing device as described in section 3.2.3. The droplets were then trapped
and their fluorescence intensity measured through fluorescence microscopy. The
fluorescein was excited with an FITC filter set (excitation 475± 35 nm, Dichoric
mirror 508 nm and emission 530 ± 43 nm). Figure 3.12 shows the fluorescein
solution when injected into the aqueous inlets and imaged through the FITC
filter set.
Figure 3.12: Pure fluorescein solution being injected into the aqueous inlets of
the device, fluorescence is observed before droplet generation has occurred. The
fluorescence is observed through an FITC filter.
Example images of droplets of fluorescein trapped in the microfluidic device
are shown in figure 3.13. These droplets (5 µm in diameter) were imaged
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and their intensities measured. The measured fluorescence intensity against
prepared fluorescein concentration is shown in figure 3.14. This shows a good
linearity with coefficient of determination, R2 = 0.99. This data provides a tool
for converting measured pixel intensities into fluorescein concentrations and
also shows the maximum observable concentration. The Andor iXon camera
used to take the images stores pixel intensities in 14 bit integers, leading to a
maximum pixel value of 214 (16384 units). From the linear fit of figure 3.14,
this corresponds to a fluorescein concentration of ∼ 38 µM. When measuring
fluorescence of droplets, a droplet is considered to have a fluorescent signal
when its intensity is over 3 times the standard deviation of the background
intensity. This was used in all experiments in this chapter where fluorescence
is observed.
(a) (b)
Figure 3.13: Droplets of fluorescein generated through a 10 µm flow focusing
nozzle were trapped in a pressure actuated trap (shown in figure 2.1) and their
fluorescence intensities measured. A standard curve of intensity was then plotted.
a) 5µM fluorescein, b) 10µM fluorescein.
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Figure 3.14: Average intensity of droplets produced from pure fluorescein so-
lution. Linearity is good and shows the limit of measurement of 38 µM. Fluores-
cence acquired with EM gain = 200 and exposure time 0.1s.
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3.3.2 Droplet Polydisperisty
During single enzyme molecule detection experiments it is essential that all
droplets are monodisperse and of a reasonable diameter (5 µm or less). This is
because polydisperse droplet populations can contain smaller droplets that will
evolve higher effective concentrations of fluorescent product over a shorter time.
After the 10 minute incubation period of the β-galactosidase/FDG reaction,
when imaged, the droplets vary in fluorescence intensity. An increase in a
single droplet intensity compared to the average droplet intensity is a sign
of multiple enzyme occupancy within a droplet. This multiple occupancy is
first controlled when the enzyme concentration to be measured is chosen, as
the capture of enzymes is Poissonian. This means that the encapsulation is a
random event and infers some statistical variation. The concentration is chosen
so that the average occupancy of a droplet is much less than 1. Therefore in
one measurement, the majority of droplets will contain no enzyme while few
will contain 1 (see table 1.3 in section 1.3). Even at some average occupancies
less than 1, there is still a finite probability of multiple enzyme occupancy. The
elimination of this multiple occupancy is essential for single molecule detection.
Elimination of polydispersity can be achieved through quality lithography,
If the droplets produced are too large, the effective concentration of fluo-
rescent product will be reduced in the droplets. Droplet volume, and therefore
concentration, scale with r3, so a droplet of diameter 8 µm (that would nor-
mally evolve a fluorescent product concentration of ∼ 24 µM) would have a
fluorescein concentration closer to 3 µM. Even if these droplets were incubated
at a longer time to reach the higher concentration, this would be in excess of 1
hour, reducing the throughput of measurements significantly. The fluorescein
may also leak from the droplets on that time scale [148]. Figure 3.15 shows a
single enzyme molecule detection experiment where the droplets produced were
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of diameter 8 µm. The resulting fluorescence image shows a signal that is not
greater than 3 S.D above background.
(a) (b)
Figure 3.15: a) 8 µm Droplets produced through a 10 µm flow focusing nozzle.
b) Fluorescent signal developed within the droplets was close to the lower limit of
detectable concentration. The droplet intensities are almost comparable to the
background. Excitation = 465-495nm, Emission = 515-555nm. Exposure time
= 0.25s.
3.3.3 Single Enzyme Detection
To carry out a single molecule enzyme experiment, the microfluidic chip was
set up as follows. Samples were prepared from aliquots. β-galactosidase was
prepared from stock by diluting with PBS (pH 7.4) + 0.1% Tween-20 to con-
centrations of 9.4 pM, 940 fM and 94 fM. These concentrations correspond to a
droplet occupancy of 0.1, 0.01 and 0.001 respectively. 50 µl of 2 mM Fluorescein
di-β-galactopyranoside (FDG) was diluted to 200 µl (500 µM) with PBS + 0.1
% Tween-20 (pH 7.4). Fluorinated oil with a block-copolymer surfactant (5 %
w/w) to stabilise the droplets was loaded into 2500 µl syringes (Hamilton 1002)
and placed in a syringe driver. β-galactosidase and FDG were loaded into 250
µl syringes (Hamilton 1725) and placed in a second syringe pump. Polyethylene
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tubing was attached to the syringe needles and interfaced with the PDMS mi-
crofluidic device. Manufacture and preparation of the microfluidic device can
be found in methods chapter 2. The samples were injected into the device and
flow rates were adjusted until stable droplet generation was achieved.
When the droplet generation was stable, the flow was diverted into the
trapping region through actuation of the control valve. The valve was activated
through introduction of air through Tygon tubing. A pressure of 30-40 PSI was
typically used (variations from device to device cause variations in required
sealing pressure). When sufficient droplets were flowing through the trapping
region, the trapping valve was activated. This valve trapped droplets in a 300 x
300 µm chamber capable of holding 5 x 104 droplets. The droplets were held for
a period of 10 minutes before being imaged through an FITC filter. The filter
excitation = 465-495 nm and emission = 515-555 nm. Images were analysed
using a MATLAB script which first analysed the bright field image and found
droplets and marked them with circles. Then, it used this as a mask to measure
the intensity within each of the detected circles. Droplets which displayed a
signal more than 3 times the standard deviation of background were considered
a positive signal.
Figure 3.16 shows a bright field and fluorescence image of a single enzyme
counting experiment. The prepared concentration of β-galactosidase was 9.4pM
corresponding to an average droplet occupancy of 0.1. Counting of droplets
in this case yielded an average occupancy (Number of fluorescent, therefore
enzyme containing, droplets/Total number of droplets) of 0.093. This corre-
sponds to a measured concentration of 8.78pM. Note in the fluorescence image
that some droplets appear to be of a higher fluorescence intensity than others.
This is due to the Poisson statistics driving the enzyme capture. Equation 3.6
shows the probability of observing k events P (k) of a capture event with av-
erage success λ. At an average of 0.1 enzyme molecules per droplet there is a
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0.4% chance of dual molecule occupancy. This is ∼ 20 droplets in a full trap of
5 x 104 droplets.
(a) (b)
Figure 3.16: a) Droplets containing β-galactosidase enzyme, trapped within the
microfluidic device. The concentration prepared = 9.4 pM b) After 10 minutes
of incubation, a fluorescence image is taken. Excitation = 465-495nm, Emission
= 515-555nm. Exposure time = 0.25s.




Figure 3.17 shows the bright field and fluorescence images of an experiment
where the prepared concentration was 940 fM (occupancy = 0.01). As expected,
lowering the enzyme concentration reduces the number of fluorescent droplets.
Plotted in figures 3.18 and 3.19 is the relationship between prepared concen-




Figure 3.17: a) 4.4µm diameter droplets trapped within the microfluidic device.
The concentration prepared = 940 fM = 1 in 100 droplets contain an enzyme.
b) After 10 minutes of incubation, a fluorescence image is taken. Excitation =
465-495nm, Emission = 515-555nm. 0.25s exposure time.
Figure 3.18: Prepared concentration vs measured concentration of β-
galactosidase encapsulated in 4 µm droplets. Inset: Zoomed view of lower mea-
sured concentrations from 47 fM to 9.4 pM. The lowest detected concentration
was 47 fM which was equivalent to 3 fluorescence droplets within a trap. n = 3.
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Figure 3.19: Prepared concentration vs measured concentration of β-
galactosidase encapsulated in 4 µm droplets shown without 47 pM data point for
clarity of lower concentrations. The lowest detected concentration was 47 fM.
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3.3.4 Summary
From this data, it can be concluded that it is possible to detect single molecules




This section will show experiments performed to detect PSA using droplet based
ELISA. Immunocomplexes were formed on 1 µm polystyrene beads as described
in section 2.7.
3.4.2 Immunocomplex Preparation
Primary anti-PSA antibodies (monoclonal mouse IgG, R&D Systems) were co-
valently bonded to 1 µm amine-functionalised polystyrene beads using a gluter-
aldehyde crosslinking kit (Polysciences). Reported in Shim et. al. [3], the con-
jugation of primary antibodies to polystyrene beads causes fluorescence when
excited at a wavelength of 560 nm and observed at 630 nm (Texas Red). Figure
3.20 shows the fluorescence present when 5 µl of fully conjugated immunocom-
plexes on beads were deposited on a glass slide. The image was taken through
a Texas Red filter (excitation = 559 nm, emission = 630 nm). Figure 3.21
shows the fluorescence when many beads collect in a region of the PDMS de-
vice (again imaged through a Texas Red filter). However, when trapped within
femtodroplets, the fluorescence could not be observed. It may be that the flu-
orescence emitted by the bead conjugates is too weak to detect or that the
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fluorescence is from the beads themselves. Intrinsic protein fluorescence oc-
curs at wavelengths much shorter than that of the emission filter of Texas Red
(Tryptophan is excited at 280 nm and emits at 350 nm) [197].
Uv-Vis spectroscopy has shown that the absorbance at 280 nm of stock anti-
PSA antibody verifies the stock concentration (3.3 µM). After conjugation, the
absorbance dropped indicating an antibody concentration of 36 nM indicating
protein conjugation had occurred.
(a) (b)
Figure 3.20: a) 5 µl of solution containing 1 µm beads with PSA immuno-
complexes conjugated were deposited onto a glass slide b) Fluorescent signal
was observed when illuminated with a Texas Red filter (Excitation = 559 nm,
emission = 620 nm).
After primary antibody conjugation, 100 µl of the biomarker sample was
incubated in 100 µl of 24 pM bead solution for 1 hour at room temperature with
gentle shaking. The beads were washed through centrifugation and resuspended
in 100 µl of fresh PBS buffer + 0.5% Tween-20 (pH 7.4) 2 times. 100 µl of
17 nM anti-PSA, biotinylated detection antibody, was added and incubated for
1 hour as before. The beads were washed 6 times through centrifugation and
resuspended in 100 µl of PBS + 0.5% Tween-20. 100 µl of 5 nM streptavidin-
conjugated β-galactosidase solution was added and incubated for 1 hour as
before. The solution was washed 6 times, resuspended in 200 µl of PBS + 0.5%
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(a) (b)
Figure 3.21: a) A bright field image of the aqueous inlet of the immunoassay
device showing a high concentration of 1 µm diameter beads with a PSA immuno-
complex conjugated. The beads accumulated within the PDMS device inlet filter.
b) A fluorescence microscopy image showed fluorescence of the beads within the
PDMS device through a Texas Red filter (Excitation = 559 nm, emission = 620
nm).
Tween-20 and sonicated for 30 minutes before injection in to the microfluidic
device.
3.4.3 Detection of PSA Biomarker in Droplet Based
ELISA.
To perform a droplet based ELISA experiment, immunocomplexes were pre-
pared on 1 µm amine-functionalised beads as described in section 2.7. This
sample solution was injected into the microfluidic device as described in the
single enzyme detection experiments (section 3.3.3). In this experiment the 2
aqueous phases were the bead bound immunocomplex solution and the FDG
substrate (500 µM). The oil phase was the same used in single enzyme detection
experiments (HFE 7500 and 5% w/w block copolymer surfactant).
After generation of femtodroplets, the aim is for a single bead to be present
within each droplet (see figure 3.22). This is so a single enzyme is digesting
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the substrate and the number of fluorescent droplets can be counted as be-
fore. As each immunocomplex should contain only one enzyme, the number of
fluorescent droplets equals the number of PSA molecules. The concentration
of immunocomplex conjugated beads is known at the start of the experiment
(typically 12 pM) so the concentration of PSA can be calculated from the ratio
of fluorescent droplets and total bead containing droplets, multiplied by the
known bead concentration.
Figure 3.23 shows a PSA detection experiment with a PSA sample concen-
tration of 30 pM. The generation of droplets was not ideal in this experiment
as some larger droplets containing many beads were present.
Figure 3.22: This bright field image shows the 1 µm beads contained within
droplets. Without the individual bead fluorescence it is still possible to determine
the presence of beads within droplets with some scrutiny.
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(a) (b)
Figure 3.23: a) A bright field image droplets trapped within the PDMS device
containing a 30 pM PSA sample. b) A fluorescence microscopy image showed
fluorescence of the droplets through an FITC filter (Excitation = 465-495 nm,
Emission = 515-555 nm. Exposure time = 0.25 s.)
3.5 Chapter Summary
The aims of this chapter were to expand the detection limits of a microfluidic
single molecule detection system to detect cancer biomarkers. During initial
experimentation to determine single enzyme concentration, the droplets that
were produced were not able to be detected using fluorescence microscopy. To
troubleshoot this experiment, the kinetics of the β-glactosidase enzyme was
investigated and this chapter lays out the further troubleshooting steps of the
individual components of the immunoassay experiment. The enzyme was found
to be active and processing the substrate at a rate that is within previously re-
ported values. The optics of the experiment were investigated and found to be
inadequate to detect the level of fluorescence product being formed within the
droplets. Polydisperse droplet formation was addressed through the analysis of
photolithography techniques and nozzle size. When the droplets were of an ac-
ceptable monodispersity, attention was focussed on the biological components.
The acquisition of new optics allowed for the detection of fluorescent prod-
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ucts from β-galactosidase and measurement of concentrations down to 47 fM.
The conjugation of antibodies onto polystyrene beads was confirmed through
UV-Vis spectroscopy although they did not exhibit the fluorescent properties
previously reported, only when many beads collected together. This could be
indicative of a weak signal that is unable to be detected on a single bead level.
This made PSA detection difficult as the method of inferring concentration
depends on knowing the number of droplets containing beads. As the beads
are 1 µm they can be elusive optically. Manual counting of beads was possi-
ble although some observations were dubious as to whether beads were being
observed or some other foreign particle. The observation of fluorescence would
be a strong indicator of bead presence and the use of fluorescent dyed beads
would be a useful addition to the experimental setup. The characterisation of
each element led to preliminary observations of a PSA immunoassay, however,
the full measurement capabilities of the microfluidic device were not observed.
To further this project, experiments would include detection of a range
of PSA concentrations possibly through the use of fluorescently tagged beads
where the fluorescenct properties are well characterised. Multiplexing of the sys-
tem can be fairly easily achieved with coded beads to detect multiple biomark-
ers. One of the main losses in the device is the number of droplets produced
that are wasted due to incubation times of trapped droplets. The integration of
an in-line detection system may improve the number of samples that are able




of Channels after Mineral Oil
Absorption
This chapter will describe the experiments undertaken to measure the pres-
sure inside a PDMS microfluidic device. The measurement of pressure within a
channel containing water under different flow rates using a unique measurement
method will be presented. This will be followed by the presentation of experi-
ments using different fluids flowing through the channel and their effect on the
pressure measurements. Finally, an analysis of the behaviour of channels after
exposure to PDMS soluble oil will be shown. Characterisation of the PDMS
before and after oil exposure will be shown with bulk swelling of PDMS, AFM
surface characterisation and Raman Spectroscopy data presented.
121
The device used in this section was a simple serpentine channel with pressure
measurement channels extending from the main channel every 50 mm. The
layout of the device is shown in figure 4.1. The dimensions of the channel are 250
µm wide, 21 µm high and 470 mm in length with 4 pressure measurement ports.
These ports were simply channels that forked off from the main channel and
led to a punched outlet. These outlets were interfaced with pressure regulators
through tubing and sealed with optical adhesive (NOA 81, see section 2.8).
4.1 Measuring the Pressure of A Microfluidic
Channel
The first steps in this project focused on measuring the internal pressure of
a PDMS microchannel. The usual approach to take these measurements is
through the use of pressure transducers that are connected to the channels. In
this project, a new method of measurement was proposed using a pressurised
air supply and gas regulators to counteract the internal pressure of the flowing
liquid until an equilibrium is reached. To validate the method for measuring
pressure, the first experiments used a flow of water within a 21 µm x 250 µm
channel at flow rates of 600 - 1800 µl/hr. The device layout in figure 4.1 shows
a 470 mm long channel with four pressure measurement ports extending out
from the main channel.
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Figure 4.1: The device used in this study comprised of 250 µm wide by 21 µm
deep channels. At 50 mm intervals, pressure measurement points are connected
to a regulated air supply. A schematic of the device setup showing the 4 pressure
measurement ports.
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4.1.1 Internal Pressure of a Rigid Channel
The pressure inside a microfluidic channel depends on the material properties
of the walls. In the devices used in these experiments, 3 of the walls are made
of PDMS (the fourth being glass) which (as described in section 1.4) deforms
under flow due to the elastic nature of the polymer. This means that under the
same flow rates, a rigid channel will experience a higher internal pressure as the
walls are not allowed to deform and increase the channel cross sectional area.
To calculate the pressure values for a rigid walled channel, the microfluidics
package of COMSOL R© Multiphysics was used. The geometry of the device was
imported and the Navier-Stokes equations for Stokes flow were solved. This
simulation resulted in the pressure values shown in figure 4.2.
4.1.2 Internal Pressure of PDMS Microchannels due to
Elastic Deformation
The measurement of pressure within a microfluidic channel was performed with
water at 21 ◦C and a viscosity of 8.9 x 10−4 Pas. The fluid was introduced
into the channel at a flow rate of 600 µl/hr through the inlet. As the fluid
flowed through the channel, the pressure regulators were adjusted so that the
pressure equalised at the interface of the channel and the measurement point.
An example of this equilibrium can be seen in figure 4.4
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Figure 4.2: When the channel walls are simulated to be non-deformable, a linear
relationship is observed between the channel position and internal pressure.
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(a) (b)
Figure 4.3: Pressure gradient of a non compliant microchannel under a flow
rate of (a) 600 µl/h and (b) 1800 µl/h. The channel geometry is 21 µm x 250
µm x 470 mm. Reynolds number, Re = 1.3 - 3.8.
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Figure 4.4: A pressure measurement point within the microfluidic device. Here
the flow of fluid has been initiated in the main channel (water) and the air
pressure off chip has been gradually increased to match the internal pressure of
the liquid. When equilibrated, an interface is formed between the flowing fluid
and external gas supply.
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When all four regulators were in equilibrium with the fluid flow, the pres-
sures were read. For flow rates of 600 µl/hr to 1800 µ/hr the resulting measured
pressures are shown in figure 4.5. The pressure is no longer linearly dependant
on channel position as the PDMS channel in able to deform under the pressure
driven flow due to its elastic properties. The higher the pressure, the higher
the deformation which increases the channels cross sectional area and reduces
the pressure compared to a rigid channel. This measured reduction confirms
that deformation is taking place.
Figure 4.5: The pressure profiles of a microfluidic channel at varying flow rates
shows a non-linear relation as expected in a deformable channel. Symbol =
experimental data, solid line = theoretical calculation.
The pressure measurements have been plotted along with theoretical pres-
sure values from the model proposed by Gervais et. al. [170] where the deforma-
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tion of the PDMS channel is modelled as flow between tapering plates resulting
in equation 4.1 (derivation of this equation is shown in section 1.4), where Q =
fluid flow rate, h0 = channel initial height, E = Young’s modulus, α = fitting
parameter, µ = fluid viscosity, L = channel length, z = channel position, p(z) =
channel internal pressure and W = channel width. This equation was solved for
p(z) in MATLAB (MathWorks, USA) at each flow rate using the Young’s Mod-
ulus measured with nanoindentaion (section 4.5) where E= (2.80 ± 0.03) MPa.
Fitting the data with these theoretical calculations showed that for this system
the proportionality constant α = 0.7 which is in line with Gervais’ predictions












From this plot it can be seen that this method for measuring pressure on
chip with the equilibrium of pressurised air and fluid flow is valid and agrees
with the model. The fact that gas is able to permeate through PDMS does
not appear to affect the measurements taken. It was theorised that there may
be sufficient surface area of the channel to allow air to escape at the pressure
measurement points, however, this does not appear to be the case even at
pressures exceeding 40 PSI.
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4.2 Initial Pressure Measurements with Min-
eral Oil
The next step was to increase the viscosity of the working fluid within the
channel to measure the difference in measured internal pressure. The motivation
was to be able to measure the internal pressure and infer the viscosity of a fluid
on-chip. The candidate fluid was mineral oil (Sigma) as it had a viscosity 30
x that of water and found to have high solubility in PDMS [209]. The viscosity
of the mineral oil was measured using a parallel plate rheometer and found to
have a viscosity of (35.6 ± 0.1) mPas.
The viscosity of the mineral oil was measured on a TA Instruments dynamic
stress rheometer (SR 500). The fluid was stressed between two parallel plates





Where γ̇ = Shear Rate(s−1), v = plate velocity(m
s
) and h = distance between
plates (m).
τ = ηγ̇ (4.3)
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where η = Viscosity (Pas) and τ = Shear Stress (Pa).
Figure 4.6: Measurement of mineral oil viscosity with a rheometer yields 35.6
± 0.1 mPas
The oil was then used as the fluid in the chip and the pressure measured.
When the viscosity was extracted from the pressure measurements it was found
to be between 9 mPas and 11 mPas, 31 % lower than the rheometer measured
value. Figure 4.7 shows the pressure drop of the channel as a function of flow
rate. The red line is a theoretical calculation of channel pressure from equation
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4.1 with flow rates between 40 and 120 µl/h, viscosity 35.6 mPas and Young’s
modulus 2.8 MPa. The black points show the measured pressure drop and it
can be seen that under current assumptions the system is not in a similar state
to the previous water pressure measurements. The interaction of mineral oil
with PDMS was then investigated as the pressure measurements did not fit
with the predicted results.
Figure 4.7: Here the red line is the theoretical pressure drop as a function
of flow rate for mineral oil of viscosity 35.6 mPas. The black points are the
measured values and correspond to a fluid viscosity of 9 mPas.
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4.3 Bulk Swelling of PDMS
PDMS is a porous polymer which leads to absorption of certain solvents when
exposed. This exposure and subsequent absorption of solvent causes the ge-
ometry of PDMS to expand when a swelling solvent diffuses into the polymer
matrix. In order to investigate the swelling effects of a solvent, the swelling
coefficient, S∞ is found. S∞ is the ratio of the polymers swollen geometry at
saturation over its initial length. The extent of swelling has been investigated
by Whitesides et. al. [210] for various solvents and found swelling coefficients of
1.01 to 2.13 for 38 different solvents.
4.3.1 Bulk Swelling with Mineral Oil
To investigate the extent of the absorption, pieces of PDMS 10 mm x 10 mm
x 5 mm were placed in a container of oil and imaged as the oil diffused into
the polymer. The surface area of the block was measured and the change over
time can be seen in figure 4.8. A final measurement was taken after swelling
had concluded, S∞. The change in surface area over time in figure 4.8 shows a
saturation at 3.7 % increase of surface area.
The diffusive process of swelling is characterised by the diffusion coefficient
D. The model of solvent diffusion into PDMS presented by Dangla et. al [209]
is shown in equation 4.5 where L(t) is the swollen length at time t, L(0) is
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Figure 4.8: Swelling of a PDMS slab over time in mineral oil. The percentage
change in surface area shows a maximum swell of 3.7 %, fit with associative
exponential.
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Figure 4.9: The swelling ratio of PDMS against
√
t gives a linear relationship.
This plot is fitted with ewuation 4.5 to extract the diffusion coefficient of mineral
oil into PDMS.
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the initial length, S∞ is the infinite swelling coefficient, d is the thickness of
the PDMS slab and t is time. This equation is valid before saturation occurs
and can be used to estimate the diffusion coefficient, D. Figure 4.9 shows the
swelling ratio S(t)-1 plotted as a function of
√
t. A linear fit was applied before
saturation and shows good fitting (R2 = 0.98). The slope, β can be used in
equation 4.6 to estimate the diffusion coefficient.
L(t)
L0












For mineral oil in PDMS, the calculated diffusion coefficient, D = (1.29 ±




is time in seconds and x is the distance of diffusion. The time taken for the oil
to diffuse the height of the channel away from the channel (21 µm above the
channel ceiling) is equal to 28.2 minutes. We can therefore assume that after a
time of 3 hours the PDMS has absorbed sufficient mineral oil to be at a swollen
steady state.
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4.4 Channel Profile Imaging with Confocal
Microscopy
4.4.1 Nile Red and Mineral Oil Solution
The cross section of the microchannel increases under pressure driven flow due
to the deformation of the PDMS channel walls. The extent of this change of
cross section was investigated with water that is negligibly absorbed by PDMS,
and mineral oil that is readily absorbed. To observe the deformation, confocal
microscopy was used. Channels were prepared using the same method as used
in the pressure measurement investigations however the pressure measurement
ports were not punched out and left sealed. Due to the short working distance of
the 40 x objective being used (∼ 200 µm), the devices were bonded to coverslips
of thickness 130 - 170 µm. The first imaging method tried was to dissolve
Nile Red dye in mineral oil to make a 1 µM solution and flow this through
the channel. The aim was to use this solution to image the oil as it flowed
through the channel under various flow rates and observe the pressure driven
deformation of the channel. Subsequent investigation showed that Nile red has
been shown to diffuse into PDMS [177] and therefore would not be suitable to
image oil as it flowed. Figure 4.10 shows the profile of a channel after a Nile
red mineral oil solution had been flowed through for 1 hour and then flushed
with water to remove fluorophore from the channel. The channel was imaged
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using a 532 nm laser as an excitation source. The resulting channel profile is
250 µm x 21 µm (pixel aspect ratio = 4.588).
Figure 4.10: Microchannel profile after flow with a Nile red mineral oil solution.
Nile red is absorbed by the PDMS and gives contrast to an empty channel.
Channel imaged under no flow after flushing with water. Dimension = 250 µm
x 21 µm.
4.4.2 Imaging of the PDMS Water interface
To investigate the deformation of channels under pressure, it was not possible to
use the Nile red solution alone. To observe the channel previously, Nile red was
removed prior to imaging with water. Here, a fluorescein solution was injected
after the mineral oil Nile red solution to image the interface of the channel flow
and PDMS. The device design was altered slightly so a thin membrane of PDMS
(100 µm) was applied as a channel base so that all walls were PDMS and could
be observed. When purging the oil from the channel and subsequently injecting
water, it is possible that the water will not fully wet the channel due to a thin
film of oil remaining. To ensure the walls of the channel were fully wetted,
the Nile red mineral oil solution was flushed with fresh mineral oil to remove
and Nile red solution in the channel and then flushed again with fluorescein
solution to remove oil. The water flush was continued until the solution had
wet the channel walls in the x-y plane and then confocal z-stacks were taken of
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the channel. The Nile red was excited with a 532 nm laser and the fluorescein
with a 488 nm laser. Figure 4.11 shows the channel profile within the Nile red
stained PDMS. Observations of the interface showed no spacial cavities between
the two fluorophores indicating the channel was fully wetted.
Figure 4.11: An overlay of Nile red and fluorescein fluorescence channels. Imag-
ing the channel with both Nile red and fluorescein allowed the visualisation of the
PDMS fluid interface. This shows that the water phase fully wets the channel
walls.
4.4.3 Confocal Microscopy of Microchannels Under
Pressure
The channels were imaged under the same flow conditions described in section
4.1.2. Under each flow rate, the channel height profile was measured by taking
z-stacks at 6 locations along the channel with a z-step of 0.53 µm. For water
deformation measurements, the devices were injected with 1 µM fluorescein
solution. In the case of mineral oil absorption, oil was flowed through the device
at a rate of 40 µl/h for 3 hours before being flushed with fluorescein solution.
Each flow rate was allowed to equilibrate for 5 minutes before imaging was
performed. z-stacks were analysed in ImageJ by translating the stacks into a
z projection before an edge detection algorithm was applied. The maximum
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height was extracted and plotted against position and flow rate.
Figure 4.12 show the heights measured when the PDMS was fresh and only
fluorescein solution was flowed. The deformation increases as a function of dis-
tance along the channel as expected. At the highest flow rate measured, 1800
µl/h, the deformation of the channel was 97.6 % higher than the original chan-
nel dimension. The deformations were plotted with theoretical deformations
(solid lines) which were calculated from equation 1.17 where proportionality
constant, α, was 0.7 as previously calculated, E = 1.35 MPa found from AFM
nanoindentation (the results of which are shown in section 4.5) and p(z) were
the previously calculated theoretical pressures from section 4.1.2.
Figure 4.12: Measured deformation (symbols) of fresh PDMS flexible mi-
crochannels compared to theoretical deformations (solid lines)
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Figure 4.13: Measured deformation (symbols) of flexible microchannels af-
ter infiltration of mineral oil compared to theoretical calculations (solid lines).




Figure 4.14: Confocal microscopy z-stacks of a channel containing fluorescein
solution under a flow rate of 1800 µl/h showing ceiling deformation at a position
460 mm from the outlet (4.14a) and 110 mm for the outlet (4.14b) The deforma-
tion of the side of the channel is measured as 2.6 µm at 460 mm from the outlet
whereas the height change is 11 µm. Scale bar = 50 µm
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4.5 Nanoindentation of PDMS with an Atomic
Force Microscope to measure Young’s
Modulus
In previous studies, the Young’s modulus of PDMS was estimated using nu-
merical simulation in order to calculate theoretical values of internal channel
pressure and channel deformation [170,172]. In this work the Young’s modulus
was measured directy using nanoindentation. To determine the Young’s mod-
ulus of PDMS, samples of fresh PDMS and oil soaked PDMS were measured
using an Atomic Force Microscope (AFM, Bruker FastScan). The tip used was
an SNL-10-D which was first tuned to obtain a spring constant and gave a value
of 0.0705 N/m. The sensitivity of the tip was calibrated with a hard silicon
sample to 316 nm/V. The sample thickness was 100 µm to avoid coupling be-
tween the sample and the glass it was bonded to as the indentation depth was
1 µm. Recommendation is that the indentation depth is no more than 10 % of
the film thickness [201]. Indentation was performed in 20 independent locations,
at least 100 µm from the previous indentation over the surface of the polymer.
The oil soaked PDMS was fully saturated with oil over a period of 6 hours
before measurement.
Figure 4.15 shows force displacement curves for the two different samples.
In order to extract the Young’s modulus of the PDMS, fitting was done using
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Bruker NanoScope analysis software. The Sneddon model (described in section
2.12) was fit for a conical indenter and the Young’s modulus found. For the
pure PDMS sample, the modulus was found to be (2.80 ± 0.03) MPa and
for the oil soaked (1.32 ± 0.04) MPa, a reduction of 53 %. This shows the
infiltration of mineral oil into the polymer matrix of PDMS effects the local
material properties dramatically.
Figure 4.15: Force displacement curves for fresh PDMS (red) and oil soaked
PDMS(black) from AFM nanoindentation. Each indentation generated a force
displacement curve from which Young’s modulus can be calculated. (curves offset
for clarity)
Using this data, the theoretical calculations of the internal channel pressure
and channel deformation could be calculated using equation 4.1 leading to plots
4.5, 4.12, 4.20 and 4.20
143
4.6 Raman Spectroscopy of Mineral Oil Ab-
sorption of PDMS
The observations with Nile red and mineral oil showed the diffusion of Nile
red into the PDMS walls of the channel. This gave a good visual indication of
absorption but could not be used to infer the diffusion of mineral oil. It cannot
be assumed that the carrier oil diffuses at the same rate as the dye therefore
another method to measure the oil permeation is required. Raman spectroscopy
was used to measure the ingress of mineral oil into the PDMS channel walls
without the presence of fluorophores. Fresh devices were prepared along with
a sample of pure mineral oil. Raman specta were taken of pure PDMS and the
mineral oil to establish characteristic peaks that will be used to track mineral
oil. Measurements were taken with a 532 nm laser for all experiments. Figure
4.16 shows the spectra obtained for pure PDMS (blue) and pure mineral oil
(red), from these spectra it can be seen that the mineral oil has a prominent
peaks at 1443 cm−1 due to CH2 and CH3 groups and 2848 cm−1, from C-
CH3 and CH2 groups, which was used as the reference peak throughout these
experiments. In order to normalise against the PDMS that the oil is diffusing
in to, the peak at 709 cm−1 was used.
To investigate the oil infiltration, a scan line was set up which started within
the channel and took spectra at intervals of 20 µm along a line perpendicular
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Figure 4.16: Raman Spectra of PDMS and Mineral oil identified characteristic
peaks.
to the channel into PDMS (see figure 4.17, right hand side). At each point a
spectra was taken with the laser at 100 % intensity (22 mW) for 1 second in
high confocality mode (22 µm slit opening) through a 40 x objective. Spectra
were acquired between 100 - 3200 cm−1 with 6 spectra within the channel and
48 outside the channel to a distance of 960 µm away from the channel wall.
The laser was focussed on the glass coverslip below the channel then moved 10
microns in z to be positioned in the middle of the channel. A scan was taken
with no oil present and then the mineral oil flow was started. At a flow rate
of 40 µl/h, spectra were acquired along the line every 5 minutes. Figure 4.17
shows the contribution of mineral oil as a function of distance from the channel
wall after a time of 75 minutes. The mineral oil peak intensity decreases further
away from the channel wall but is still present within the PDMS. Figure 4.18
shows the spectra at time points 0, 40 and 75 minutes from when the oil flow
started. The prominent peak in the centre of each plot is due to PDMS and
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Figure 4.17: Raw Raman spectra shows the contribution of mineral oil as a
function of distance from the channel wall. The Raman intensity can be seen to
drop off as the scan progresses into the bulk PDMS. Time = 75 minutes therefore
the bulk PDMS is saturated with oil.
the peak to the left is due to mineral oil contributions.
The normalised intensity of the PDMS was plotted against time and posi-
tion in figure 4.19 and show the evolution of the increasing intensity further
away from the channel edge over time. The plot indicates the the mineral oil is
diffusing into the PDMS to a great enough degree that on the scale of the defor-
mations that are being observed, the PDMS Young’s modulus can be considered
to be that which was measured by AFM nanoindentation. Independent of Nile
red infiltration, this result shows the diffusion of mineral oil into PDMS over












































































































































modulus. Figure 4.19 shows that even after 20 minutes, the mineral oil has
infiltrated the polymer matrix further than 50 µm allowing for the observed
channel deformations.
Figure 4.19: Normalised intensities of the 2848 cm−1 mineral oil peak against
distance and time show the diffusion of oil into the PDMS polymer matrix.
Contour lines show lines of equal normalised intensities.
4.7 Pressure Measurements with Mineral Oil
After investigating the interaction of PDMS with mineral oil, the pressure mea-
surements were repeated. During the first measurement of pressure with min-
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eral oil as the flowing fluid (described in section 4.2) there was constant diffusion
of oil into the PDMS while the experiment was taking place. This infiltration
was constantly changing the Young’s modulus of the PDMS leading to inaccu-
rate results. Here, the mineral oil was flowed through the channel at a flow rate
of 40 µl/h for 3 hours before being flushed with water and then internal channel
pressure measured. The change in Young’s modulus measured with nanoinden-
tation was applied to the theoretical model and a new set of theoretical values
calculated. When plotted with measured results as shown in figure 4.20 it can
be seen that the change in Young’s modulus provides a good match to explain
the change in deformation measured.
Figure 4.20: The pressure of microchannels after mineral oil flow show lower
pressures than in the fresh PDMS case. The reduced Young’s modulus allowed
for greater deformation, therefore larger channel surface area and lower pressures.
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4.8 Conclusions
In this chapter the internal pressure of microfluidic channels was investigated.
A novel way to measure on chip microchannel pressure was devised using a
pressurised air supply along with pressure regulators to equilibrate the chan-
nel pressure and read off a full channel pressure profile. Measured pressure
for regular PDMS channels agreed with previously published theory [170,172] for
deformable channels. This showed that the theories provided were valid for
channels that were longer than previously reported, even using a sepentine de-
sign. The introduction of a solvent that diffuses into PDMS introduced a chal-
lenge as the internal pressures and deformations no longer agreed with theory.
Bulk swelling experiments allowed the determination of the diffusion coefficient
of mineral oil into PDMS and subsequent Raman spectroscopy measurements
visualised the infiltration of oil into the polymer matrix. Changes in material
properties were measured through AFM nanoindentation and revealed a 53 %
reduction on Young’s modulus after mineral oil infiltration. This new Young’s
modulus was used to calculate new theoretical internal pressures and deforma-
tions which matched experimental results. The deformation of channels was
seen with confocal microscopy for both pure PDMS and PDMS after oil infil-
tration. PDMS remains a popular choice for microfluidic devices, especially in
cell culture experiments as its gas permeability is key in maintaining a suit-
able atmosphere for cellular culture. However, the diffusion of molecules into
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PDMS can cause issues as signalling molecules or even drugs can appear to
vanish from studies [43]. The deformation of PDMS microchannels is important
in blood vessel simulations in which the geometry of the vessel can change due
to increased blood pressure. The ability to design devices which mimic these







The aim of this chapter is to present the motivations and iterations of a mi-
crofluidic device to perform expansion microscopy. The target biological sample
was mouse cardiomyocytes that had been induced with heart failure. The aim
of the expansion is to image ryanodine receptors responsible for muscle con-
tractions as a result of this heart failure [187]. The four iterations of the device
will be presented as well as images from attempts to polymerise acrylamide
gel within channels containing cardiomyocytes. The general operating princi-
ple of an experiment is that cardiomyocytes are suspended in the acrylamide
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monomer solution, which is then mixed with the initiator and accelerator be-
fore injection into the channel [179–181]. Different concentrations of initiator and
accelerator were used and will be explained at relevant points. In this chapter,
all preparation of biological samples (cardiomyocyte cells), gel components and
gel compositions were performed by Tom Sheard of Biological Sciences.
The composition of the monomer solution is shown in table 5.1
Component Stock Conc. Amount (ml) Final Conc.*
Sodium acrylate 38 2.25 8.6




Sodium chloride 29.2 4 11.7
PBS 10X 1 1X
Water 0.9
Total 9.4**
Table 5.1: Monomer Composition - *all concentrations in g/100 ml except PBS
- **9.4/10 ml, the remaining 0.6 ml is made up by the initiator and accelerator.










Initiator Solution (APS) 4
Table 5.2: Standard recipe for the preparation of 200 µl of gelling solution.
Component Amount
Tris buffer pH 8.0 50 mM
EDTA 1 mM
Triton X-100 0.5 %
Guanidine HCL 0.8 M
Proteinase K 8 units/ml
Table 5.3: Standard recipe for the preparation of digestion buffer
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5.1 Initial Device Design, A Sliding Gel Block
The first proposed device design is shown in figure 5.2. The device comprises
of a flow layer, shown as green and blue and the yellow control layer. Green
layer is 40 µm high and the blue layer is an additional 40 µm on top of the
green, 80 µm total. The yellow control valves are 25 µm in height and are on
top of the flow layer. Usually in multilayer device fabrication, the valve layers
are on the bottom of the device in contact with the glass. However, when these
devices are to be used in a high resolution confocal microscope, the available
required objectives have working distances of 200 µm. If the devices layers
were arranged in the conventional orientation, the thickness of coverslip (130-
170 µm) plus the valve height and membrane (25 and 15 µm) would limit the
imaging ability. The reversal of the layers allows for 30 - 70 µm of imageable
channel in the device. The gelation would occur between valves A and B then
a force applied from flow at inlet 2 would cause the solid gel to slide into the
expansion area at the left of the device.
Cardiomyocytes are cylindrical in shape with length 100 µm and diameter
10 - 25 µm [187]. A cardiomyocyte that has had staining applied to its actinin
microfilament proteins is shown in figure 5.1. The image was taken on a slide
after ProLong Gold Antifade Mountant (ThermoFisher) had been applied. Pro-
Long Gold is a liquid mountant applied directly to fluorescently labelled cells
or tissues on microscope slides. It protects dyes from fading during fluores-
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cence imaging. This image represents the optimal image to obtain within the
microfluidic device.
Figure 5.1: A cardiomyocyte imaged on a slide after actinin staining. A layer
of ProLong Gold antifade solution has been applied to protect fluorophores from
bleaching. Image provided by Tom Sheard.
The principle of operation is that the device is first filled with PBS buffer
to remove all air bubbles present. The valves are activated with water in the
tubing to push out the air inside the fingers until they are full of water. The gel
solution is prepared off chip and immediately injected into the device through
inlet 2. During the injection, valve A is activated and inlet 1 is blocked. The gel
solution flows between inlet 2 and outlet 3 until sufficient cells have entered the
area between the two valves. The thin channels of 1 and 3 are 30 µm to prevent
the cells escaping the intended area. At this point the injection is stopped and
valve B is activated. Buffer is flowed through inlet 1 to flush the right hand
side of the device of gel solution before the device is left to allow polymerisation
to occur. After polymerisation there should be a gel slab present within the
channel. Valves A and B would be released and the slab pushed through to
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the expansion area by injecting a PBS buffer flow in inlet 2. Once the slab had
moved, valve A would be activated to isolate the expansion area. Digestion
buffer flows between inlets 4 and 5 overnight at room temperature to digest
the cell structure. Finally, PBS buffer replaces the digestion buffer and the gel
expands.
Figure 5.2: This two layered device is designed to trap cardiomyocytes in
acrylamide gel solution between valves at A and B. After gelation, the gel slab
is moved to the expansion chamber (blue) for digestion and expansion. The blue
and green layers are 40 µm each (total 80 µm in the expansion area) and the
yellow valves are 25 µm thick.
Initial experimentation involved the injection of cells to verify the devices
trapping ability. The first cell injections showed that the side channels at 50
µm were too large to stop cells escaping. This is shown in figure 5.3 where the
cells have begun to infiltrate the side channels. Figure 5.3a shows the cells after
full injection of the solution, the gelation area has concentrated the cells. This
will make the cells more difficult to resolve later in the imaging process so the
concentration was lowered by ten times for injection in figure 5.3b. Note, the
channels either side of the main channel were present on some designs on the
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same wafer as design 1, they were removed after this iteration.
(a)
(b)
Figure 5.3: (a) The accumulation of cells in the gelation area is too high and
the cells are beginning to infiltrate the outer channels. (b) A lower concentration
of cells is advantageous but again they show egress from the main channel.
Figure 5.4 shows a small cluster of cells after injection of gel solution. After
leaving the gel to solidify for four hours the pressure was released. It was
immediately apparent that the gelation had not been successful as the solution
remains liquid when the valve was released. In the experiments described up
to this point, the concentration of initiator (APS) and accelerator (TEMED)
were 0.1 %. Repeating the process and leaving the gel to cure overnight had
no impact and the solution remained liquid.
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Figure 5.4: A small cluster of cells inside the gelation chamber after injection.
The cells remained in this position and the gel solution remained liquid.
5.2 Device Revision 2 - A smaller gelation area
The second revision of the device is shown in figure 5.5. In this design the
size of the gelation chamber was reduced to 750 µm in length to allow for the
formation of a smaller gel slab. This was to make transportation of the gel into
the expansion chamber easier. Another feature to aid this transition was to
extend the 80 µm layer of the device to the edge of the gelation chamber where
the step in height could aid the release of the slab. Inlet 1 has also been moved
into the same area as valve B. This was to attempt to reduce the possibility of
gel clogging up the channels when polymerising. If excess gel was present in
device 1, it was possible that the slab was immovable.
Cells were injected into the device with a higher APS/TEMED concentra-
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Figure 5.5: Device iteration 2 improved some of the failures of device 1. The
50 µm side channels were reduced to 30 µm and the step in height up to 80 µm
was moved up to the gelation chamber edge.
tion of 0.2 % and the inhibitor 4-hydroxy-TEMPO removed. At 0.1 %, outside
of the chip, the gel became solid after 12 minutes. At 0.2 % the solution became
solid in approximately 30 s indicating that there is likely transport of some of
the initiator and/or accelerator into the PDMS walls of the device. Figure 5.6
show cells that have been loaded into the device with a 0.2 % APS/TEMED
concentration. After an overnight incubation the gel solution was still liquid
and at this point no gel had been observed on chip. It could be suggested
that the gel solution itself was not functioning correctly but observations of the
syringe and tubing interfacing with the device disagree. Any gel remaining in
the syringe became solid in the same time frame as described earlier, indicating
that the PDMS was interfering with gelation.
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(a) (b)
Figure 5.6: (a) Cells were trapped in the 750 µm length gelation area. (b)
After an overnight incubation to gelate, the solution was still liquid.
5.3 Device Revision 3 - Pocket based cell cap-
ture
Changes to the device were quite radical at this point. The idea of a gel slab
was discarded in favour of individual pockets where gel could form. Shown in
figure 5.7, the device consists of an area to diffuse cells along the width of the
device when injected into inlet 1 to enable even distribution into the traps. The
traps consist of walls that are 100 µm wide in a U shape. At the bottom of each
trap there is a 35 µm gap to allow the laminar flow to draw cells into the traps.
The yellow section shown in figure 5.7b is a large scale valve that covers the
entire trap area. When casting the PDMS onto this relief pattern the resulting
chamber will include the curved traps on the ceiling of the device. As can be
seen in figure 5.7a, the trap moulds do not extend to the base of the device but
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down to the first 40 µm layer. This feature means that gel can be polymerised
in the traps while pressure is applied to the whole ceiling, pushing the traps
down onto the device base. After curing, the pressure is released and should
leave behind 40 µm high gel droplets. After injection of liquid gel solution and
application of pressure, buffer can be flowed into inlet 3 or 4 in an attempt to
flush gel away from the traps to isolate them from each other. However, due to
the similarity in viscosity and miscibility, this was not possible.
(a)
(b)
Figure 5.7: The third device design incorporated pressure actuated traps in
an attempt to form discrete compartments of gel. The yellow valve layer is
positioned on top of the blue 80 µm layer.
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As the gel was not polymerising on chip, an APS/TEMED solution was used
as the working fluid in the valve above the traps. This was done to provide
a reservoir of molecules for the polymerisation process. Channels were also
soaked in APS/TEMED solutions overnight to saturate the PDMS with the
initiator and accelerator.
(a) (b)
Figure 5.8: (a) Successful crosslinking of acrylamide gel after 60 hours. The
trap pressure is still applied. (b) After the release of pressure, the gel stays intact.
Cells were injected with concentration of 0.2 % and 0.3 % APS/TEMED
solutions to maximise the chance of crosslinking. The 0.2 % behaved as before
and no gelation occurred after 60 hours. However, the 0.3 % solution success-
fully crosslinked after 60 hours and can be seen in figure 5.8. The gel appears
to have formed in a way in which it has no contact with the PDMS of the traps.
This could be due to the gel drying up after such a long period of incubation
(The edges of the gel look like they could be dry, a high magnification is shown
in figure 5.9) or by some surface tension effects that arise when the gel is form-
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ing. As the gel formation appears to be slow as at a time of 48 hours after
injection the chamber was observed to be full of liquid.
Figure 5.9: The gel has formed away from the pockets either through some
drying or surface tension effects.
5.4 Device Revision 4 - Larger Trap Chambers
The next revision is shown in figure 5.10 and is similar in principle to version
3. The chambers have been made larger, 500 µm across and 800 µm long.
The motivation for this design change was derived from the behaviour of the
gel in the previous version. If it was possible to make the gel form away from
the PDMS surface then this shape of trap would encourage the formation of
individual discrete gel compartments. The cell inlet (number 1) was increased
in height to 80 µm as the cells were bottlenecked at this area in the previous
design. This change was to encourage a good distribution of cells across the
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trapping layer. As before, the trap was actuated with APS/TEMED solution
and the channels were soaked before use.
(a)
(b)
Figure 5.10: Design 4 refines the traps in order to encourage gel to form as it
did in device 3. The traps are 500 µm x 800 µm x 40 µm. The valve layer is
positioned on top of the traps as previously described.
Gelation occurred in this device on a handful of occasions. Interestingly the
best gelation was seen at and APS/TEMED concentration of 0.2 % which failed
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on previous devices. The 0.3 % APS/TEMED solutions did not gelate at all on
this device. Figure 5.11 shows gelation in two of the devices. The expectation
was that the gel would form into discrete compartments inside the traps but
this does not appear to be the case. These gels were observed after 72 hours
and appeared to still be liquid at 48 hours. There is a thin gel piece extending
from the entrance/exits of the traps which could indicate that a narrowing of
the opening could in fact form discrete areas of gel.
(a) (b)
Figure 5.11: Gelation with a 0.2% APS/TEMED solution was achieved. The
gel solution did not form discrete compartments as expected.
Cells were imaged within the polymerised gel solution to ensure the fluores-
cence tags had not been damaged after long polymerisation times. Shown in
figure 5.12, two cells demonstrated that the fluorescence had not been lost and
the cells structure had remained intact. Under stress the cells can lose their




Figure 5.12: (a) and (c) show cardiomyocyte cells in place within an acrylamide
gel structure. The fluorescence of the cells (b) and (d) was not lost during the
acrylamide polymerisation time of 72 hours.
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5.5 Conclusions
The aim of this project was to develop a microfluidic device to encapsulate
cardiomyocytes within an acrylamide gel to perform expansion microscopy.
Through iterations of the device design, gelation on chip has been success-
ful. Initially gelation appeared to be inhibited by PDMS, possibly through
loss of initiator and accelerator and this was resolved by the addition of an
APS/TEMED reservoir in valves above the gelation. After successful gelation
the device was optimised to try and force discrete compartments of gel to en-
able multiple expansion measurements. However, the current version does not
cause this to occur. Cells were shown to be successfully embedded within the
gel without degradation of fluorescence due to long cure times at room temper-
ature. The future of this device will either take the form of refinement of the
traps to encourage compartmentalisation or a droplet based approach where
single cells can be encapsulated in droplets and then incubated on chip to poly-
merise. This may offer an advantage whereby the contents of the droplet will





The aim of chapter 3 was to expand the detectable concentration of prostate
specific antigen (PSA) with microfluidic immunoassay. Characterisation of mi-
crofluidic droplet generation through flow focusing nozzles was performed and
showed good performance of 6 - 10 µm wide nozzles for generation of droplets
stably to 4 µm. The detection of single molecules of β-galactosidase was initially
elusive as no detectable fluorescent product was seen during experimentation.
Kinetic studies of the enzyme confirmed it was functioning as expected and sub-
sequent investigation led to a change in optical microscopes. With new optics
the fluorescence was detectable and the concentration of β-galactosidase was
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measured down to a value of 47 fM. This paved the way for immunoassay and
PSA detection. Characterisation of the immunocomplex conjugation confirmed
the binding of primary antibodies to polystyrene beads even though previously
reported fluorescence properties were unable to be replicated in single droplets
but were apparent in high bead concentrations. Due to this lack of fluorescence
the beads were difficult to distinguish in the droplet traps and therefore PSA
detection was inaccurate. The full immunocomplex conjugation was shown to
be functional as fluorescence was detected in droplets when formed with bead
immunocomplexes and enzyme substrate FDG. The substitution of the beads
for a bar-coded or alternatively tagged fluorescent bead could lead to improve-
ment of PSA detection and pave the way for multiplexed detection of various
biomarkers. As it stands, the multiplexed detection of biomarkers is generally
reserved for research [211], developers of immunoassay believe that the technol-
ogy can lead to portable, in-home devices that could monitor a range of general
health biomarkers without requiring medical trained personnel [88].
Further aims of this chapter that were not realised were a redesign of the
current microfluidic device in order to take advantage of wasted droplets gen-
erated within the device and utilise them for measurement. In the current
configuration, the device is capable of holding 200,000 droplets at one time, a
theoretical limit of detection of 4.7 fM. The current capture efficiency of beads
within the device is 10 % which would need to be greatly improved to lower the
170
LOD even further. The investigation of rapid detection of droplet fluorescence
may be useful to try and utilise wasted droplets although the practicalities
of implementing such detection would greatly increase the complexity of the
system.
6.2 On-chip Pressure Measurements
The experimental aim in Chapter 4 was to develop a novel method of measuring
the pressure inside a PDMS microchannel. This was achieved with a pressurised
air supply and regulators to counteract the pressure inside the channel and
measure it. This alternative to pressure transducers was shown to match well to
published theories on the internal pressure of a compliant polymer microchannel
which is advantageous for more complex microfluidic chip designs as we ll as
the simple straight channels presented in previous work. The introduction of
mineral oil into a PDMS channel caused the measured pressures to deviate
from the theory. Due to the mineral oil being absorbed by the PDMS, the
local mechanical properties of the channel walls changed. To investigate, the
bulk swelling of PDMS was observed and a 3.5 % increase in surface area was
shown when immersed in oil. Raman spectroscopy was used to demonstrate the
infiltration of mineral oil through tracking of a strong Raman peak intensity
into the PDMS over time. This showed infiltration on the order of 100 µm
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within 60 minutes. The mechanical properties of mineral oil soaked PDMS were
investigated using AFM nanoindentation showing a 53 % decrease in Young’s
modulus when compared to fresh PDMS. This reduced Young’s modulus was
applied to the deformation theory and along with confocal imaging of channels
under pressure provided a good match for measurements with oil soaked PDMS.
The measurements of pressure induced deformation demonstrated before these
experiments were performed estimate the value of Young’s modulus based on
observations made. The coupling of measured modulus and pre-existing theory
reinforces
Potential further experiments could include the characterisation of other
molecules diffusing into PDMS such as cellular signalling molecules or drugs
as these have been found to disappear from PDMS microfluidic channels. The
changing of PDMS material properties has been shown to be of use in the de-
tection of solvent vapour when expansions cause a circuit to close activating an
RFID loop [212]. The understanding of pressure within microchannels is leading
to understanding of other processes such as droplet generation and the coupling




An on chip acrylamide expansion microscopy system was developed in chapter
5 as currently no such solution exists. The devices developed from a system
where gel could be formed and then moved into another part of the device to
an array of traps with the possibility of confining individual compartments of
gel for expansion in situ. Initial runs with standard concentrations of polymeri-
sation initiator and accelerator yielded no solid gel inside a microfluidic device
even though all gel contained within the interfacing tubing and delivery syringe
was solid. The leading theory states that PDMS is absorbing one or both of
these molecules and inhibiting the polymerisation. In further iterations of the
device, the use of a device wide valve enabled the introduction of a reservoir
of initiator and crosslinker above the gelation channel. This change enabled
the formation of gel under high initial concentrations of initiator and acceler-
ator coupled with the above channel reservoir. At this point the formation of
discrete gel compartments has not been achieved but the latest device design
shows great promise. For further iterations, the use of droplet microfluidics
might enable easy formation of gel spheres to trap cardiomyocytes and expand
them once cell digestion has occurred. This could lead to a system where many
different cell types could be imaged using expansion microscopy. Currently in
the field of expansion microscopy, the protocol remains relatively unchanged.
The development of a microfluidic based system could greatly enhance the ac-
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cessibility of expansion microscopy through the production of a generic system.
Very little literature exists regarding the coupling of expansion microscopy and
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